# ref_drug_names

standard_name: Abatacept
created_at: 2026-02-17 11:12:14
raw_name:
Orencia 125mg/1ml solution for injection pre-filled syringes (Bristol-Myers Squibb Pharmaceuticals Ltd)


standard_name: Abatacept
created_at: 2026-02-17 11:12:14
raw_name:
ORENCIA CLICKJECT 125MG/1ML SOLUTION FOR INJECTION PRE-FILLED PENS (BRISTOL-MYERS SQUIBB PHARMACEUTICALS LTD)


standard_name: ROMIPLOSTIM
created_at: 2026-02-17 11:12:14
raw_name:
ROMIPLOSTIM 250MICROGRAM POWDER AND SOLVENT FOR SOLUTION FOR INJECTION PRE-FILLED DISPOSABLE DEVICES


standard_name: misc
created_at: 2026-02-17 11:12:14
raw_name:
TRIOMEL 7G/LITRE NITROGEN 1140KCAL/LITRE WITH ELECTROLYTES INFUSION 2LITRE BAGS (BAXTER HEALTHCARE LTD)


# pathway_nodes

date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £6,554
first_seen: 2019-09-23
last_seen: 2025-09-29
first_seen_parent: 2020-04-02
last_seen_parent: 2024-10-20
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12 times with a 7.5 weekly interval (90.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 9 times with a 4.9 weekly interval (44.1 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 188.8, "avg_administrations": 12}, {"drug": "USTEKINUMAB", "avg_dose_mg": 384.8, "avg_administrations": 17}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ADALIMUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £5,196
first_seen: 2019-12-14
last_seen: 2025-01-30
first_seen_parent: 2021-01-23
last_seen_parent: 2025-03-31
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21 times with a 4.9 weekly interval (102.9 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 14 times with a 9.0 weekly interval (126.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 480.4, "avg_administrations": 18}, {"drug": "NIVOLUMAB", "avg_dose_mg": 118.1, "avg_administrations": 16}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £15,616
first_seen: 2021-05-07
last_seen: 2025-10-18
first_seen_parent: 2017-07-05
last_seen_parent: 2024-09-25
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 176.3, "avg_administrations": 25}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12 times with a 2.3 weekly interval (27.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £10,700
first_seen: 2020-05-16
last_seen: 2025-12-18
first_seen_parent: 2019-11-01
last_seen_parent: 2024-10-07
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 339.1, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 9 times with a 2.9 weekly interval (26.1 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £20,336
first_seen: 2021-04-17
last_seen: 2024-09-25
first_seen_parent: 2019-12-02
last_seen_parent: 2025-04-18
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 452.4, "avg_administrations": 5}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 4 times with a 7.4 weekly interval (29.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - USTEKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - USTEKINUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £10,273
first_seen: 2022-08-28
last_seen: 2024-10-02
first_seen_parent: 2020-06-10
last_seen_parent: 2024-04-13
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 8 times with a 8.9 weekly interval (71.2 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 11 times with a 4.6 weekly interval (50.6 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 89.0, "avg_administrations": 21}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 328.4, "avg_administrations": 28}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - USTEKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - USTEKINUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £9,916
first_seen: 2021-03-20
last_seen: 2024-04-27
first_seen_parent: 2021-05-21
last_seen_parent: 2024-05-18
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 23 times with a 4.1 weekly interval (94.3 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 24 times with a 10.9 weekly interval (261.6 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 223.8, "avg_administrations": 8}, {"drug": "ETANERCEPT", "avg_dose_mg": 351.2, "avg_administrations": 5}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £7,457
first_seen: 2021-10-06
last_seen: 2025-06-05
first_seen_parent: 2017-03-31
last_seen_parent: 2025-09-05
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 209.4, "avg_administrations": 20}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 10 times with a 4.4 weekly interval (44.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - TOFACITINIB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £5,730
first_seen: 2020-03-08
last_seen: 2024-11-26
first_seen_parent: 2018-12-10
last_seen_parent: 2024-10-23
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 4 times with a 4.8 weekly interval (19.2 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 23 times with a 5.3 weekly interval (121.9 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 55.3, "avg_administrations": 9}, {"drug": "BARICITINIB", "avg_dose_mg": 295.4, "avg_administrations": 7}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £5,804
first_seen: 2019-10-28
last_seen: 2024-12-14
first_seen_parent: 2020-08-11
last_seen_parent: 2024-07-03
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 112.9, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 15 times with a 9.6 weekly interval (144.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £18,236
first_seen: 2019-04-25
last_seen: 2024-04-15
first_seen_parent: 2019-05-28
last_seen_parent: 2024-02-10
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 224.0, "avg_administrations": 7}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 16 times with a 8.4 weekly interval (134.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - ADALIMUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £11,809
first_seen: 2019-10-22
last_seen: 2025-06-18
first_seen_parent: 2018-04-17
last_seen_parent: 2024-08-01
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22 times with a 2.2 weekly interval (48.4 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 27 times with a 3.0 weekly interval (81.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 436.8, "avg_administrations": 22}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 492.4, "avg_administrations": 13}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £4,713
first_seen: 2019-09-10
last_seen: 2024-10-20
first_seen_parent: 2017-04-18
last_seen_parent: 2024-10-30
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 448.4, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16 times with a 5.9 weekly interval (94.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - INFLIXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - INFLIXIMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £5,039
first_seen: 2021-05-19
last_seen: 2025-06-24
first_seen_parent: 2021-04-02
last_seen_parent: 2025-10-26
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 24 times with a 6.1 weekly interval (146.4 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 11 times with a 8.3 weekly interval (91.3 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 475.4, "avg_administrations": 12}, {"drug": "ETANERCEPT", "avg_dose_mg": 190.6, "avg_administrations": 13}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - INFLIXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - INFLIXIMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £6,830
first_seen: 2020-11-30
last_seen: 2025-05-23
first_seen_parent: 2019-03-28
last_seen_parent: 2025-09-19
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7 times with a 3.2 weekly interval (22.4 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 20 times with a 7.8 weekly interval (156.0 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 214.9, "avg_administrations": 18}, {"drug": "SECUKINUMAB", "avg_dose_mg": 217.1, "avg_administrations": 5}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £7,708
first_seen: 2020-05-01
last_seen: 2024-01-26
first_seen_parent: 2019-03-22
last_seen_parent: 2025-12-13
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 100.5, "avg_administrations": 5}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7 times with a 9.3 weekly interval (65.1 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £13,936
first_seen: 2021-03-09
last_seen: 2024-06-08
first_seen_parent: 2019-10-08
last_seen_parent: 2025-11-18
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4 times with a 6.4 weekly interval (25.6 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 16 times with a 7.5 weekly interval (120.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 288.8, "avg_administrations": 18}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 83.0, "avg_administrations": 11}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £12,496
first_seen: 2019-08-04
last_seen: 2024-03-29
first_seen_parent: 2019-11-16
last_seen_parent: 2024-01-18
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 348.2, "avg_administrations": 20}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5 times with a 6.9 weekly interval (34.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - IBRUTINIB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £8,223
first_seen: 2022-10-18
last_seen: 2025-03-15
first_seen_parent: 2019-08-05
last_seen_parent: 2025-03-14
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 6 times with a 11.6 weekly interval (69.6 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 28 times with a 8.7 weekly interval (243.6 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 74.3, "avg_administrations": 19}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 234.3, "avg_administrations": 5}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £14,234
first_seen: 2020-08-23
last_seen: 2025-03-29
first_seen_parent: 2017-11-05
last_seen_parent: 2024-01-10
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 257.1, "avg_administrations": 27}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 26 times with a 2.2 weekly interval (57.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £11,741
first_seen: 2018-09-21
last_seen: 2025-09-12
first_seen_parent: 2018-07-14
last_seen_parent: 2024-10-13
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 376.8, "avg_administrations": 8}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 27 times with a 9.7 weekly interval (261.9 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £13,044
first_seen: 2020-08-21
last_seen: 2025-09-20
first_seen_parent: 2018-10-16
last_seen_parent: 2025-03-15
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 280.3, "avg_administrations": 19}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 30 times with a 3.7 weekly interval (111.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £24,461
first_seen: 2018-12-06
last_seen: 2025-04-15
first_seen_parent: 2020-09-17
last_seen_parent: 2025-12-22
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 437.0, "avg_administrations": 12}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 17 times with a 11.5 weekly interval (195.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - BEVACIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - BEVACIZUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £5,939
first_seen: 2022-06-12
last_seen: 2025-10-20
first_seen_parent: 2019-08-07
last_seen_parent: 2024-04-23
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 22 times with a 5.7 weekly interval (125.4 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 19 times with a 6.1 weekly interval (115.9 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 244.2, "avg_administrations": 27}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 133.9, "avg_administrations": 15}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - BEVACIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - BEVACIZUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £6,620
first_seen: 2019-04-14
last_seen: 2025-11-02
first_seen_parent: 2021-01-27
last_seen_parent: 2025-08-16
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 11 times with a 2.6 weekly interval (28.6 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 21 times with a 5.7 weekly interval (119.7 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 476.7, "avg_administrations": 11}, {"drug": "ADALIMUMAB", "avg_dose_mg": 194.0, "avg_administrations": 26}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £24,125
first_seen: 2018-11-29
last_seen: 2024-12-26
first_seen_parent: 2020-09-30
last_seen_parent: 2025-09-09
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 163.7, "avg_administrations": 17}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5 times with a 7.8 weekly interval (39.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - NIVOLUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - NIVOLUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £10,263
first_seen: 2019-02-16
last_seen: 2024-03-19
first_seen_parent: 2021-07-09
last_seen_parent: 2024-01-03
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 15 times with a 4.6 weekly interval (69.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 30 times with a 2.2 weekly interval (66.0 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 392.1, "avg_administrations": 9}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 154.1, "avg_administrations": 19}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - NIVOLUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - NIVOLUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £3,848
first_seen: 2021-02-07
last_seen: 2024-05-29
first_seen_parent: 2020-06-24
last_seen_parent: 2025-12-08
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 28 times with a 4.2 weekly interval (117.6 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 29 times with a 9.7 weekly interval (281.3 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 402.2, "avg_administrations": 5}, {"drug": "ADALIMUMAB", "avg_dose_mg": 418.3, "avg_administrations": 7}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £8,018
first_seen: 2021-04-19
last_seen: 2025-10-14
first_seen_parent: 2018-07-19
last_seen_parent: 2024-05-03
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 411.3, "avg_administrations": 29}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 4 times with a 4.2 weekly interval (16.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £9,031
first_seen: 2021-03-04
last_seen: 2024-09-04
first_seen_parent: 2018-06-19
last_seen_parent: 2024-06-10
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 310.6, "avg_administrations": 15}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 24 times with a 3.7 weekly interval (88.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £3,754
first_seen: 2020-12-29
last_seen: 2024-04-07
first_seen_parent: 2017-04-18
last_seen_parent: 2024-05-26
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 481.0, "avg_administrations": 27}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 19 times with a 5.2 weekly interval (98.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £27,934
first_seen: 2021-07-12
last_seen: 2024-05-27
first_seen_parent: 2020-09-26
last_seen_parent: 2024-05-09
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 436.7, "avg_administrations": 11}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 22 times with a 2.7 weekly interval (59.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - RANIBIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £15,577
first_seen: 2022-05-19
last_seen: 2024-01-07
first_seen_parent: 2021-02-04
last_seen_parent: 2024-02-05
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 22 times with a 3.0 weekly interval (66.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 21 times with a 8.4 weekly interval (176.4 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 50.9, "avg_administrations": 18}, {"drug": "RITUXIMAB", "avg_dose_mg": 116.9, "avg_administrations": 16}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £17,498
first_seen: 2021-06-21
last_seen: 2024-05-04
first_seen_parent: 2018-11-01
last_seen_parent: 2024-05-03
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 182.1, "avg_administrations": 4}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 28 times with a 7.9 weekly interval (221.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £13,318
first_seen: 2019-06-30
last_seen: 2024-12-29
first_seen_parent: 2019-10-18
last_seen_parent: 2025-05-13
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 461.2, "avg_administrations": 6}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 14 times with a 3.5 weekly interval (49.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £16,309
first_seen: 2018-11-11
last_seen: 2025-03-24
first_seen_parent: 2019-07-16
last_seen_parent: 2024-01-21
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 134.9, "avg_administrations": 19}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 5 times with a 11.1 weekly interval (55.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £19,273
first_seen: 2020-01-05
last_seen: 2024-04-23
first_seen_parent: 2019-10-19
last_seen_parent: 2024-10-15
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 109.7, "avg_administrations": 27}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 5 times with a 10.6 weekly interval (53.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £20,037
first_seen: 2018-05-12
last_seen: 2025-07-08
first_seen_parent: 2017-12-24
last_seen_parent: 2024-08-20
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 484.3, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 19 times with a 7.8 weekly interval (148.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £18,383
first_seen: 2018-01-21
last_seen: 2025-08-19
first_seen_parent: 2018-08-16
last_seen_parent: 2025-04-11
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 453.8, "avg_administrations": 29}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 4 times with a 4.0 weekly interval (16.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £15,431
first_seen: 2021-12-24
last_seen: 2024-09-15
first_seen_parent: 2019-02-11
last_seen_parent: 2024-08-26
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 18 times with a 8.9 weekly interval (160.2 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 17 times with a 10.5 weekly interval (178.5 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 460.3, "avg_administrations": 14}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 308.7, "avg_administrations": 20}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £21,057
first_seen: 2018-09-01
last_seen: 2025-04-04
first_seen_parent: 2019-01-30
last_seen_parent: 2025-09-03
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 349.5, "avg_administrations": 22}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 16 times with a 4.0 weekly interval (64.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £23,029
first_seen: 2021-03-17
last_seen: 2024-07-04
first_seen_parent: 2017-04-14
last_seen_parent: 2024-02-15
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 74.9, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 10 times with a 2.3 weekly interval (23.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £4,047
first_seen: 2019-09-30
last_seen: 2025-04-01
first_seen_parent: 2021-06-09
last_seen_parent: 2025-05-07
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 4.7 weekly interval (84.6 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 28 times with a 3.6 weekly interval (100.8 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 178.5, "avg_administrations": 4}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 276.7, "avg_administrations": 26}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £19,126
first_seen: 2021-10-26
last_seen: 2024-07-29
first_seen_parent: 2019-03-20
last_seen_parent: 2024-07-12
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 233.2, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7 times with a 7.0 weekly interval (49.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £26,424
first_seen: 2020-10-24
last_seen: 2025-02-12
first_seen_parent: 2019-03-26
last_seen_parent: 2024-03-27
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 136.1, "avg_administrations": 17}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 29 times with a 8.2 weekly interval (237.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - TOFACITINIB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £15,071
first_seen: 2021-10-10
last_seen: 2025-06-14
first_seen_parent: 2020-03-13
last_seen_parent: 2025-01-03
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 8 times with a 6.7 weekly interval (53.6 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 26 times with a 6.2 weekly interval (161.2 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 390.2, "avg_administrations": 18}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 485.8, "avg_administrations": 6}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - TOFACITINIB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £12,967
first_seen: 2021-09-29
last_seen: 2025-07-20
first_seen_parent: 2018-03-20
last_seen_parent: 2025-05-17
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 10 times with a 2.1 weekly interval (21.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 21 times with a 11.0 weekly interval (231.0 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 406.8, "avg_administrations": 11}, {"drug": "INFLIXIMAB", "avg_dose_mg": 440.3, "avg_administrations": 20}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £18,666
first_seen: 2018-02-04
last_seen: 2024-10-28
first_seen_parent: 2020-06-29
last_seen_parent: 2025-01-11
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 87.3, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 25 times with a 4.4 weekly interval (110.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £5,560
first_seen: 2022-05-19
last_seen: 2025-11-23
first_seen_parent: 2019-08-06
last_seen_parent: 2025-12-19
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 12 times with a 9.6 weekly interval (115.2 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 16 times with a 8.0 weekly interval (128.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 444.7, "avg_administrations": 19}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 330.1, "avg_administrations": 9}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £6,113
first_seen: 2019-08-18
last_seen: 2024-03-25
first_seen_parent: 2018-03-10
last_seen_parent: 2025-08-04
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 8 times with a 9.3 weekly interval (74.4 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 24 times with a 3.1 weekly interval (74.4 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 324.8, "avg_administrations": 21}, {"drug": "NIVOLUMAB", "avg_dose_mg": 381.1, "avg_administrations": 22}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £19,428
first_seen: 2019-04-24
last_seen: 2024-07-21
first_seen_parent: 2019-01-04
last_seen_parent: 2024-02-09
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 297.7, "avg_administrations": 21}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 19 times with a 9.7 weekly interval (184.3 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - IBRUTINIB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £11,973
first_seen: 2020-05-06
last_seen: 2025-12-04
first_seen_parent: 2019-10-02
last_seen_parent: 2024-11-15
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 26 times with a 5.2 weekly interval (135.2 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 13 times with a 6.1 weekly interval (79.3 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 404.4, "avg_administrations": 26}, {"drug": "ETANERCEPT", "avg_dose_mg": 448.8, "avg_administrations": 20}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £16,358
first_seen: 2021-12-12
last_seen: 2024-06-10
first_seen_parent: 2019-01-05
last_seen_parent: 2025-02-10
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 336.8, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 17 times with a 3.8 weekly interval (64.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £19,470
first_seen: 2019-07-18
last_seen: 2025-12-21
first_seen_parent: 2020-05-31
last_seen_parent: 2025-07-09
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 164.0, "avg_administrations": 4}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 10 times with a 6.9 weekly interval (69.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - OCRELIZUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £13,350
first_seen: 2021-06-14
last_seen: 2025-05-04
first_seen_parent: 2018-05-01
last_seen_parent: 2025-09-21
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 4 times with a 11.3 weekly interval (45.2 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 6 times with a 7.3 weekly interval (43.8 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 414.7, "avg_administrations": 21}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 443.0, "avg_administrations": 5}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - OCRELIZUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £3,975
first_seen: 2021-07-06
last_seen: 2024-11-06
first_seen_parent: 2020-07-20
last_seen_parent: 2024-10-20
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 12 times with a 7.3 weekly interval (87.6 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 20 times with a 8.4 weekly interval (168.0 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 480.1, "avg_administrations": 22}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 165.5, "avg_administrations": 24}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £23,689
first_seen: 2018-08-29
last_seen: 2025-03-27
first_seen_parent: 2019-12-02
last_seen_parent: 2024-04-28
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 81.5, "avg_administrations": 11}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 14 times with a 2.9 weekly interval (40.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - NATALIZUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £4,693
first_seen: 2021-01-30
last_seen: 2025-08-08
first_seen_parent: 2020-11-07
last_seen_parent: 2025-09-21
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 22 times with a 3.9 weekly interval (85.8 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 6 times with a 2.6 weekly interval (15.6 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 273.9, "avg_administrations": 10}, {"drug": "NIVOLUMAB", "avg_dose_mg": 336.7, "avg_administrations": 30}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £8,994
first_seen: 2021-11-14
last_seen: 2025-04-29
first_seen_parent: 2017-12-25
last_seen_parent: 2024-08-25
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 123.8, "avg_administrations": 21}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 25 times with a 7.5 weekly interval (187.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £26,807
first_seen: 2020-09-27
last_seen: 2024-03-22
first_seen_parent: 2018-09-18
last_seen_parent: 2025-06-18
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 271.4, "avg_administrations": 10}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 15 times with a 9.2 weekly interval (138.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - NIVOLUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - NIVOLUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £12,370
first_seen: 2020-08-12
last_seen: 2025-07-08
first_seen_parent: 2020-08-12
last_seen_parent: 2025-01-05
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: NIVOLUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 8 times with a 5.5 weekly interval (44.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 26 times with a 4.1 weekly interval (106.6 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 137.4, "avg_administrations": 5}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 426.2, "avg_administrations": 5}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - NIVOLUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - NIVOLUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £19,505
first_seen: 2020-12-31
last_seen: 2025-08-20
first_seen_parent: 2018-04-26
last_seen_parent: 2025-10-11
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: NIVOLUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 21 times with a 5.2 weekly interval (109.2 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 9 times with a 6.3 weekly interval (56.7 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 152.9, "avg_administrations": 15}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 88.4, "avg_administrations": 18}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £12,134
first_seen: 2018-01-28
last_seen: 2025-07-03
first_seen_parent: 2017-12-05
last_seen_parent: 2025-03-19
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 290.7, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 12 times with a 10.7 weekly interval (128.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £21,904
first_seen: 2019-11-03
last_seen: 2024-08-11
first_seen_parent: 2019-04-29
last_seen_parent: 2024-11-02
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5 times with a 5.9 weekly interval (29.5 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 12 times with a 10.0 weekly interval (120.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 152.3, "avg_administrations": 5}, {"drug": "BARICITINIB", "avg_dose_mg": 499.0, "avg_administrations": 28}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £14,948
first_seen: 2021-09-09
last_seen: 2024-06-08
first_seen_parent: 2019-02-08
last_seen_parent: 2024-01-21
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 457.2, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 30 times with a 3.2 weekly interval (96.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £17,172
first_seen: 2022-02-14
last_seen: 2025-07-10
first_seen_parent: 2019-12-04
last_seen_parent: 2024-01-07
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 18 times with a 6.9 weekly interval (124.2 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 11 times with a 3.2 weekly interval (35.2 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 91.6, "avg_administrations": 9}, {"drug": "TOFACITINIB", "avg_dose_mg": 315.0, "avg_administrations": 13}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £11,176
first_seen: 2021-03-23
last_seen: 2025-06-22
first_seen_parent: 2020-04-23
last_seen_parent: 2024-02-16
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 7 times with a 9.7 weekly interval (67.9 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 14 times with a 8.9 weekly interval (124.6 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 156.7, "avg_administrations": 25}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 222.9, "avg_administrations": 4}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £12,338
first_seen: 2020-02-02
last_seen: 2025-01-24
first_seen_parent: 2018-12-21
last_seen_parent: 2024-06-16
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 346.6, "avg_administrations": 10}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 26 times with a 9.4 weekly interval (244.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £8,004
first_seen: 2022-01-08
last_seen: 2025-06-12
first_seen_parent: 2018-02-16
last_seen_parent: 2024-10-05
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 13 times with a 3.1 weekly interval (40.3 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 21 times with a 9.6 weekly interval (201.6 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 367.7, "avg_administrations": 18}, {"drug": "IBRUTINIB", "avg_dose_mg": 171.8, "avg_administrations": 24}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £5,544
first_seen: 2020-07-21
last_seen: 2025-07-10
first_seen_parent: 2019-01-03
last_seen_parent: 2025-07-13
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4 times with a 11.0 weekly interval (44.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 12 times with a 5.8 weekly interval (69.6 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 413.3, "avg_administrations": 18}, {"drug": "TOFACITINIB", "avg_dose_mg": 126.0, "avg_administrations": 21}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £9,332
first_seen: 2021-06-02
last_seen: 2025-11-01
first_seen_parent: 2019-08-31
last_seen_parent: 2025-04-10
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 147.0, "avg_administrations": 16}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 30 times with a 7.3 weekly interval (219.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £15,128
first_seen: 2018-10-06
last_seen: 2025-11-10
first_seen_parent: 2018-07-01
last_seen_parent: 2024-12-05
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 233.7, "avg_administrations": 23}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8 times with a 3.0 weekly interval (24.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £7,743
first_seen: 2019-01-12
last_seen: 2025-01-02
first_seen_parent: 2018-02-09
last_seen_parent: 2025-06-19
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 438.5, "avg_administrations": 9}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 4 times with a 9.6 weekly interval (38.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - USTEKINUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £13,990
first_seen: 2020-06-04
last_seen: 2024-02-21
first_seen_parent: 2020-11-22
last_seen_parent: 2024-11-04
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 23 times with a 4.6 weekly interval (105.8 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 19 times with a 9.2 weekly interval (174.8 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 409.4, "avg_administrations": 16}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 381.8, "avg_administrations": 8}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £6,871
first_seen: 2021-10-09
last_seen: 2024-03-24
first_seen_parent: 2020-12-25
last_seen_parent: 2024-11-30
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 471.0, "avg_administrations": 20}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 12 times with a 6.4 weekly interval (76.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - SECUKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - SECUKINUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £19,011
first_seen: 2021-09-11
last_seen: 2025-03-04
first_seen_parent: 2021-04-01
last_seen_parent: 2024-10-26
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 8 times with a 2.2 weekly interval (17.6 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 17 times with a 10.6 weekly interval (180.2 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 385.0, "avg_administrations": 27}, {"drug": "ADALIMUMAB", "avg_dose_mg": 70.2, "avg_administrations": 25}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £14,033
first_seen: 2020-08-14
last_seen: 2025-08-27
first_seen_parent: 2019-03-12
last_seen_parent: 2024-11-27
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 180.9, "avg_administrations": 20}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 23 times with a 8.1 weekly interval (186.3 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £13,629
first_seen: 2020-02-04
last_seen: 2024-02-14
first_seen_parent: 2019-10-24
last_seen_parent: 2024-12-28
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 58.8, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17 times with a 8.1 weekly interval (137.7 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £14,347
first_seen: 2018-06-09
last_seen: 2025-12-18
first_seen_parent: 2019-09-04
last_seen_parent: 2024-01-25
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 191.0, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 23 times with a 5.8 weekly interval (133.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £19,290
first_seen: 2019-02-15
last_seen: 2024-03-07
first_seen_parent: 2017-04-03
last_seen_parent: 2024-08-26
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 200.3, "avg_administrations": 18}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 27 times with a 5.1 weekly interval (137.7 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - ADALIMUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £17,798
first_seen: 2021-02-21
last_seen: 2024-03-20
first_seen_parent: 2019-01-26
last_seen_parent: 2024-05-21
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10 times with a 4.5 weekly interval (45.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 20 times with a 6.0 weekly interval (120.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 103.1, "avg_administrations": 10}, {"drug": "RITUXIMAB", "avg_dose_mg": 363.9, "avg_administrations": 7}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - ADALIMUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £15,752
first_seen: 2021-02-01
last_seen: 2024-04-23
first_seen_parent: 2021-05-10
last_seen_parent: 2025-04-20
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 5.4 weekly interval (97.2 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 17 times with a 4.4 weekly interval (74.8 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 339.1, "avg_administrations": 27}, {"drug": "NIVOLUMAB", "avg_dose_mg": 130.3, "avg_administrations": 18}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £9,300
first_seen: 2019-08-29
last_seen: 2025-02-16
first_seen_parent: 2019-07-06
last_seen_parent: 2025-02-11
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 245.1, "avg_administrations": 7}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 15 times with a 3.7 weekly interval (55.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - USTEKINUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £20,858
first_seen: 2019-08-04
last_seen: 2025-06-27
first_seen_parent: 2021-11-18
last_seen_parent: 2025-05-31
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 16 times with a 2.7 weekly interval (43.2 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 29 times with a 7.6 weekly interval (220.4 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 429.8, "avg_administrations": 18}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 161.0, "avg_administrations": 20}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £8,459
first_seen: 2019-03-17
last_seen: 2024-12-06
first_seen_parent: 2019-11-19
last_seen_parent: 2025-03-30
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 319.6, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 25 times with a 5.0 weekly interval (125.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £9,463
first_seen: 2018-08-30
last_seen: 2025-04-14
first_seen_parent: 2017-12-07
last_seen_parent: 2025-08-14
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 271.0, "avg_administrations": 7}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 13 times with a 5.5 weekly interval (71.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - TOFACITINIB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £9,452
first_seen: 2022-08-30
last_seen: 2024-01-07
first_seen_parent: 2018-07-06
last_seen_parent: 2025-12-05
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 29 times with a 5.7 weekly interval (165.3 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 24 times with a 7.2 weekly interval (172.8 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 377.3, "avg_administrations": 8}, {"drug": "IBRUTINIB", "avg_dose_mg": 244.2, "avg_administrations": 10}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - TOFACITINIB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £16,844
first_seen: 2022-05-20
last_seen: 2025-09-26
first_seen_parent: 2021-04-15
last_seen_parent: 2025-09-16
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 9 times with a 11.8 weekly interval (106.2 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 21 times with a 7.7 weekly interval (161.7 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 454.3, "avg_administrations": 27}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 299.0, "avg_administrations": 13}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £11,636
first_seen: 2020-07-06
last_seen: 2024-10-14
first_seen_parent: 2020-03-05
last_seen_parent: 2024-09-29
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 63.3, "avg_administrations": 27}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 16 times with a 7.5 weekly interval (120.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £3,633
first_seen: 2018-05-19
last_seen: 2025-01-01
first_seen_parent: 2019-10-20
last_seen_parent: 2025-11-28
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 205.3, "avg_administrations": 11}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 25 times with a 11.5 weekly interval (287.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £9,818
first_seen: 2022-02-26
last_seen: 2025-08-07
first_seen_parent: 2019-11-29
last_seen_parent: 2024-04-03
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 26 times with a 11.2 weekly interval (291.2 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 23 times with a 11.9 weekly interval (273.7 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 161.0, "avg_administrations": 25}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 457.3, "avg_administrations": 18}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £8,796
first_seen: 2022-11-06
last_seen: 2025-01-21
first_seen_parent: 2019-10-24
last_seen_parent: 2025-05-13
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 17 times with a 5.9 weekly interval (100.3 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 27 times with a 9.0 weekly interval (243.0 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 484.9, "avg_administrations": 19}, {"drug": "NIVOLUMAB", "avg_dose_mg": 316.7, "avg_administrations": 21}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £11,313
first_seen: 2020-02-15
last_seen: 2025-06-27
first_seen_parent: 2019-01-31
last_seen_parent: 2024-08-23
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 300.1, "avg_administrations": 9}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 8 times with a 8.7 weekly interval (69.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - LENALIDOMIDE - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £3,520
first_seen: 2021-06-14
last_seen: 2025-06-26
first_seen_parent: 2018-09-05
last_seen_parent: 2025-03-12
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 18 times with a 3.9 weekly interval (70.2 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 5 times with a 9.6 weekly interval (48.0 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 350.2, "avg_administrations": 27}, {"drug": "TOFACITINIB", "avg_dose_mg": 276.8, "avg_administrations": 29}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £15,477
first_seen: 2019-04-06
last_seen: 2024-01-30
first_seen_parent: 2020-10-24
last_seen_parent: 2025-06-28
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 313.0, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 29 times with a 4.6 weekly interval (133.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £14,929
first_seen: 2019-01-03
last_seen: 2024-09-16
first_seen_parent: 2019-10-30
last_seen_parent: 2025-12-13
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 6 times with a 5.9 weekly interval (35.4 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 21 times with a 6.8 weekly interval (142.8 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 286.5, "avg_administrations": 28}, {"drug": "NATALIZUMAB", "avg_dose_mg": 464.3, "avg_administrations": 16}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £13,066
first_seen: 2018-08-15
last_seen: 2025-03-23
first_seen_parent: 2020-02-01
last_seen_parent: 2025-09-13
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 357.0, "avg_administrations": 9}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 27 times with a 2.8 weekly interval (75.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £11,495
first_seen: 2020-03-25
last_seen: 2025-02-24
first_seen_parent: 2019-04-11
last_seen_parent: 2025-11-18
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 187.2, "avg_administrations": 20}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 22 times with a 7.4 weekly interval (162.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £11,322
first_seen: 2019-04-21
last_seen: 2024-07-25
first_seen_parent: 2020-01-19
last_seen_parent: 2025-01-20
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 22 times with a 7.7 weekly interval (169.4 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 5 times with a 11.3 weekly interval (56.5 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 206.6, "avg_administrations": 29}, {"drug": "INFLIXIMAB", "avg_dose_mg": 487.7, "avg_administrations": 13}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £19,685
first_seen: 2019-10-10
last_seen: 2024-06-12
first_seen_parent: 2019-04-16
last_seen_parent: 2025-03-19
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 6 times with a 2.9 weekly interval (17.4 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 26 times with a 5.7 weekly interval (148.2 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 251.0, "avg_administrations": 24}, {"drug": "BARICITINIB", "avg_dose_mg": 296.3, "avg_administrations": 10}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £8,333
first_seen: 2021-01-05
last_seen: 2024-05-13
first_seen_parent: 2018-09-20
last_seen_parent: 2024-05-07
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 308.8, "avg_administrations": 15}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 6 times with a 10.6 weekly interval (63.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £15,868
first_seen: 2020-02-27
last_seen: 2024-09-22
first_seen_parent: 2017-07-14
last_seen_parent: 2025-10-20
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 119.3, "avg_administrations": 22}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 20 times with a 10.8 weekly interval (216.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - PEMBROLIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - PEMBROLIZUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £18,600
first_seen: 2022-07-22
last_seen: 2025-04-12
first_seen_parent: 2019-05-14
last_seen_parent: 2025-11-11
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 25 times with a 7.3 weekly interval (182.5 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 8 times with a 7.1 weekly interval (56.8 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 460.6, "avg_administrations": 21}, {"drug": "USTEKINUMAB", "avg_dose_mg": 61.7, "avg_administrations": 16}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £14,223
first_seen: 2018-01-03
last_seen: 2025-06-14
first_seen_parent: 2017-06-17
last_seen_parent: 2024-01-06
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 458.0, "avg_administrations": 16}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 15 times with a 9.2 weekly interval (138.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £3,999
first_seen: 2020-02-03
last_seen: 2025-01-20
first_seen_parent: 2018-07-29
last_seen_parent: 2024-11-29
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 450.6, "avg_administrations": 15}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 29 times with a 5.6 weekly interval (162.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £12,436
first_seen: 2021-06-15
last_seen: 2025-11-13
first_seen_parent: 2017-10-04
last_seen_parent: 2024-07-25
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 128.6, "avg_administrations": 19}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16 times with a 4.1 weekly interval (65.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £14,575
first_seen: 2018-05-16
last_seen: 2024-10-05
first_seen_parent: 2020-09-27
last_seen_parent: 2025-06-05
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 270.6, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 18 times with a 11.7 weekly interval (210.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - RANIBIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £14,187
first_seen: 2021-12-22
last_seen: 2024-03-05
first_seen_parent: 2018-10-19
last_seen_parent: 2024-05-24
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 13 times with a 7.4 weekly interval (96.2 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 16 times with a 3.8 weekly interval (60.8 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 221.3, "avg_administrations": 11}, {"drug": "TOFACITINIB", "avg_dose_mg": 419.3, "avg_administrations": 7}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - RANIBIZUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £12,525
first_seen: 2019-08-22
last_seen: 2024-11-19
first_seen_parent: 2020-12-28
last_seen_parent: 2024-04-14
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 11 times with a 10.6 weekly interval (116.6 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 11 times with a 4.4 weekly interval (48.4 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 158.5, "avg_administrations": 7}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 428.2, "avg_administrations": 21}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £8,129
first_seen: 2021-04-07
last_seen: 2025-09-10
first_seen_parent: 2020-06-08
last_seen_parent: 2025-10-07
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 340.6, "avg_administrations": 30}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 19 times with a 10.9 weekly interval (207.1 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £10,319
first_seen: 2020-07-07
last_seen: 2024-07-19
first_seen_parent: 2020-08-20
last_seen_parent: 2024-11-16
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 159.2, "avg_administrations": 19}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 30 times with a 6.2 weekly interval (186.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ADALIMUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £3,693
first_seen: 2020-11-18
last_seen: 2024-06-11
first_seen_parent: 2018-04-10
last_seen_parent: 2024-08-10
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 27 times with a 10.7 weekly interval (288.9 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 27 times with a 5.8 weekly interval (156.6 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 444.1, "avg_administrations": 14}, {"drug": "BARICITINIB", "avg_dose_mg": 261.1, "avg_administrations": 16}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £12,686
first_seen: 2019-02-27
last_seen: 2024-01-29
first_seen_parent: 2018-11-25
last_seen_parent: 2024-07-16
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 407.5, "avg_administrations": 29}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13 times with a 8.9 weekly interval (115.7 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ETANERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ETANERCEPT - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £7,027
first_seen: 2019-01-01
last_seen: 2024-11-01
first_seen_parent: 2018-07-21
last_seen_parent: 2024-02-06
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 16 times with a 8.1 weekly interval (129.6 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 29 times with a 10.0 weekly interval (290.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 410.2, "avg_administrations": 23}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 375.2, "avg_administrations": 25}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £22,299
first_seen: 2021-06-02
last_seen: 2024-10-26
first_seen_parent: 2018-03-22
last_seen_parent: 2024-11-06
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 448.9, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 24 times with a 6.7 weekly interval (160.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £3,520
first_seen: 2021-03-09
last_seen: 2024-06-21
first_seen_parent: 2020-02-17
last_seen_parent: 2024-08-12
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 222.0, "avg_administrations": 13}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 16 times with a 6.9 weekly interval (110.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ADALIMUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £13,316
first_seen: 2020-04-05
last_seen: 2025-10-29
first_seen_parent: 2019-12-04
last_seen_parent: 2025-02-07
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 26 times with a 5.6 weekly interval (145.6 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 17 times with a 3.4 weekly interval (57.8 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 346.8, "avg_administrations": 12}, {"drug": "ETANERCEPT", "avg_dose_mg": 299.8, "avg_administrations": 27}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £14,167
first_seen: 2018-10-23
last_seen: 2025-04-22
first_seen_parent: 2017-12-03
last_seen_parent: 2024-08-12
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 298.9, "avg_administrations": 30}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 25 times with a 8.9 weekly interval (222.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £10,285
first_seen: 2018-08-31
last_seen: 2024-05-10
first_seen_parent: 2020-11-29
last_seen_parent: 2024-06-04
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 50.6, "avg_administrations": 12}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 13 times with a 4.9 weekly interval (63.7 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £15,909
first_seen: 2020-05-14
last_seen: 2024-06-21
first_seen_parent: 2018-04-07
last_seen_parent: 2025-08-13
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 24 times with a 9.8 weekly interval (235.2 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 13 times with a 10.0 weekly interval (130.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 134.7, "avg_administrations": 18}, {"drug": "NIVOLUMAB", "avg_dose_mg": 148.7, "avg_administrations": 22}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £7,632
first_seen: 2021-12-16
last_seen: 2024-03-09
first_seen_parent: 2021-03-17
last_seen_parent: 2025-12-15
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 26 times with a 10.1 weekly interval (262.6 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 28 times with a 11.8 weekly interval (330.4 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 106.5, "avg_administrations": 18}, {"drug": "RITUXIMAB", "avg_dose_mg": 56.6, "avg_administrations": 28}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £17,471
first_seen: 2019-07-19
last_seen: 2024-01-28
first_seen_parent: 2020-07-24
last_seen_parent: 2024-09-03
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 251.5, "avg_administrations": 29}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10 times with a 5.1 weekly interval (51.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £6,973
first_seen: 2020-10-13
last_seen: 2024-07-22
first_seen_parent: 2020-03-21
last_seen_parent: 2024-06-12
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 185.1, "avg_administrations": 30}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 12 times with a 10.7 weekly interval (128.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £22,487
first_seen: 2021-01-27
last_seen: 2025-01-01
first_seen_parent: 2019-11-03
last_seen_parent: 2025-11-24
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 183.3, "avg_administrations": 17}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 23 times with a 8.3 weekly interval (190.9 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - TOFACITINIB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £5,576
first_seen: 2021-11-05
last_seen: 2024-04-12
first_seen_parent: 2018-05-04
last_seen_parent: 2025-06-16
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 30 times with a 3.4 weekly interval (102.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 7 times with a 9.1 weekly interval (63.7 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 113.2, "avg_administrations": 4}, {"drug": "SECUKINUMAB", "avg_dose_mg": 481.8, "avg_administrations": 9}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £17,464
first_seen: 2021-08-26
last_seen: 2024-11-07
first_seen_parent: 2018-06-16
last_seen_parent: 2025-10-20
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 432.1, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 28 times with a 10.9 weekly interval (305.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £22,307
first_seen: 2021-03-01
last_seen: 2024-07-30
first_seen_parent: 2017-06-29
last_seen_parent: 2025-02-12
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 393.5, "avg_administrations": 7}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 21 times with a 3.5 weekly interval (73.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £20,687
first_seen: 2021-06-23
last_seen: 2025-06-08
first_seen_parent: 2018-02-09
last_seen_parent: 2024-03-08
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 315.0, "avg_administrations": 8}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 14 times with a 6.9 weekly interval (96.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £18,885
first_seen: 2021-10-28
last_seen: 2025-01-20
first_seen_parent: 2018-03-11
last_seen_parent: 2025-03-29
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 110.8, "avg_administrations": 30}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 15 times with a 6.6 weekly interval (99.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £11,235
first_seen: 2020-05-30
last_seen: 2025-08-13
first_seen_parent: 2021-05-05
last_seen_parent: 2024-05-03
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 20 times with a 3.7 weekly interval (74.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 7 times with a 11.7 weekly interval (81.9 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 236.6, "avg_administrations": 10}, {"drug": "ADALIMUMAB", "avg_dose_mg": 259.3, "avg_administrations": 9}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £5,161
first_seen: 2018-11-08
last_seen: 2024-07-08
first_seen_parent: 2017-08-26
last_seen_parent: 2024-06-13
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 304.5, "avg_administrations": 9}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 18 times with a 4.0 weekly interval (72.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - NATALIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £11,622
first_seen: 2022-03-06
last_seen: 2025-11-13
first_seen_parent: 2018-09-22
last_seen_parent: 2024-08-23
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 17 times with a 7.9 weekly interval (134.3 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 14 times with a 10.0 weekly interval (140.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 103.4, "avg_administrations": 13}, {"drug": "SECUKINUMAB", "avg_dose_mg": 459.1, "avg_administrations": 26}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £15,929
first_seen: 2020-02-04
last_seen: 2025-11-19
first_seen_parent: 2020-04-14
last_seen_parent: 2025-02-28
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 85.4, "avg_administrations": 19}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 5 times with a 5.1 weekly interval (25.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £17,814
first_seen: 2018-01-27
last_seen: 2025-08-23
first_seen_parent: 2017-08-04
last_seen_parent: 2024-08-25
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 135.4, "avg_administrations": 23}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 24 times with a 11.2 weekly interval (268.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £21,415
first_seen: 2018-08-07
last_seen: 2025-12-04
first_seen_parent: 2020-09-30
last_seen_parent: 2024-02-18
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 74.5, "avg_administrations": 23}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 27 times with a 2.0 weekly interval (54.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £10,479
first_seen: 2020-01-05
last_seen: 2025-07-06
first_seen_parent: 2021-06-17
last_seen_parent: 2025-08-18
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12 times with a 9.5 weekly interval (114.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 8 times with a 2.7 weekly interval (21.6 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 94.7, "avg_administrations": 14}, {"drug": "SECUKINUMAB", "avg_dose_mg": 320.9, "avg_administrations": 30}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £8,127
first_seen: 2021-04-03
last_seen: 2024-04-13
first_seen_parent: 2019-02-18
last_seen_parent: 2024-08-25
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 406.2, "avg_administrations": 8}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 26 times with a 7.3 weekly interval (189.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £10,756
first_seen: 2020-01-31
last_seen: 2025-08-31
first_seen_parent: 2019-04-18
last_seen_parent: 2024-01-29
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 490.2, "avg_administrations": 24}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 18 times with a 3.0 weekly interval (54.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £3,798
first_seen: 2020-02-22
last_seen: 2024-04-12
first_seen_parent: 2020-10-09
last_seen_parent: 2025-12-20
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 8 times with a 11.6 weekly interval (92.8 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 24 times with a 9.0 weekly interval (216.0 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 295.8, "avg_administrations": 10}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 215.8, "avg_administrations": 6}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £11,410
first_seen: 2019-12-24
last_seen: 2025-09-29
first_seen_parent: 2021-03-31
last_seen_parent: 2024-05-24
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 21 times with a 9.0 weekly interval (189.0 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 18 times with a 10.2 weekly interval (183.6 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 198.5, "avg_administrations": 15}, {"drug": "BARICITINIB", "avg_dose_mg": 287.0, "avg_administrations": 13}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £6,016
first_seen: 2021-09-25
last_seen: 2024-11-28
first_seen_parent: 2018-09-30
last_seen_parent: 2024-01-10
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 59.8, "avg_administrations": 15}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 9 times with a 9.2 weekly interval (82.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £24,901
first_seen: 2020-01-21
last_seen: 2025-10-20
first_seen_parent: 2020-09-06
last_seen_parent: 2024-05-16
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 494.6, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 13 times with a 5.2 weekly interval (67.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - BARICITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - BARICITINIB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £16,039
first_seen: 2021-09-25
last_seen: 2025-05-07
first_seen_parent: 2021-07-10
last_seen_parent: 2024-09-23
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 19 times with a 4.3 weekly interval (81.7 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 17 times with a 7.6 weekly interval (129.2 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 176.4, "avg_administrations": 4}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 209.5, "avg_administrations": 30}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £15,975
first_seen: 2021-01-21
last_seen: 2025-04-11
first_seen_parent: 2017-09-24
last_seen_parent: 2024-06-29
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 270.0, "avg_administrations": 29}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 6 times with a 10.9 weekly interval (65.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - INFLIXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - INFLIXIMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £16,830
first_seen: 2021-03-08
last_seen: 2025-05-16
first_seen_parent: 2020-04-16
last_seen_parent: 2024-09-20
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 30 times with a 7.2 weekly interval (216.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 12 times with a 6.7 weekly interval (80.4 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 209.0, "avg_administrations": 18}, {"drug": "TOFACITINIB", "avg_dose_mg": 490.0, "avg_administrations": 23}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £16,258
first_seen: 2018-11-09
last_seen: 2025-06-08
first_seen_parent: 2018-05-29
last_seen_parent: 2024-12-20
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 257.2, "avg_administrations": 16}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 13 times with a 9.2 weekly interval (119.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £11,466
first_seen: 2019-07-11
last_seen: 2025-09-24
first_seen_parent: 2017-09-12
last_seen_parent: 2025-06-06
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 410.3, "avg_administrations": 16}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 16 times with a 11.8 weekly interval (188.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £6,100
first_seen: 2021-12-06
last_seen: 2025-07-16
first_seen_parent: 2020-04-15
last_seen_parent: 2024-11-08
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 291.1, "avg_administrations": 11}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 26 times with a 7.6 weekly interval (197.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - SECUKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - SECUKINUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £7,777
first_seen: 2019-05-18
last_seen: 2024-07-24
first_seen_parent: 2020-02-28
last_seen_parent: 2025-09-09
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 19 times with a 10.1 weekly interval (191.9 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 5 times with a 9.9 weekly interval (49.5 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 369.8, "avg_administrations": 15}, {"drug": "NIVOLUMAB", "avg_dose_mg": 467.3, "avg_administrations": 20}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £7,291
first_seen: 2021-03-24
last_seen: 2025-10-25
first_seen_parent: 2017-06-15
last_seen_parent: 2024-03-13
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 228.1, "avg_administrations": 24}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 20 times with a 11.6 weekly interval (232.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - USTEKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - USTEKINUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £12,879
first_seen: 2019-01-25
last_seen: 2025-03-14
first_seen_parent: 2018-06-26
last_seen_parent: 2024-11-08
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 27 times with a 10.5 weekly interval (283.5 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 5 times with a 9.1 weekly interval (45.5 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 399.9, "avg_administrations": 5}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 305.4, "avg_administrations": 10}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £13,575
first_seen: 2021-05-02
last_seen: 2025-05-06
first_seen_parent: 2018-12-29
last_seen_parent: 2024-12-20
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 300.1, "avg_administrations": 13}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 25 times with a 4.1 weekly interval (102.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £6,688
first_seen: 2021-02-04
last_seen: 2025-08-16
first_seen_parent: 2017-06-02
last_seen_parent: 2025-02-01
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 494.0, "avg_administrations": 28}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 5.6 weekly interval (100.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £22,940
first_seen: 2018-01-09
last_seen: 2025-08-14
first_seen_parent: 2018-04-11
last_seen_parent: 2024-08-22
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 391.9, "avg_administrations": 11}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 6 times with a 7.1 weekly interval (42.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £10,069
first_seen: 2021-12-15
last_seen: 2025-04-12
first_seen_parent: 2017-03-22
last_seen_parent: 2024-11-02
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 304.0, "avg_administrations": 29}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 6.5 weekly interval (117.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £6,602
first_seen: 2019-02-12
last_seen: 2024-10-07
first_seen_parent: 2020-03-04
last_seen_parent: 2024-06-19
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 456.0, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 9 times with a 4.9 weekly interval (44.1 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £16,797
first_seen: 2022-10-12
last_seen: 2025-05-29
first_seen_parent: 2018-11-25
last_seen_parent: 2025-02-16
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 7 times with a 8.3 weekly interval (58.1 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 24 times with a 3.7 weekly interval (88.8 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 481.6, "avg_administrations": 6}, {"drug": "SECUKINUMAB", "avg_dose_mg": 334.9, "avg_administrations": 4}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £20,944
first_seen: 2022-11-24
last_seen: 2025-07-25
first_seen_parent: 2018-10-27
last_seen_parent: 2024-06-20
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 9 times with a 6.4 weekly interval (57.6 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 13 times with a 4.3 weekly interval (55.9 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 242.5, "avg_administrations": 15}, {"drug": "NIVOLUMAB", "avg_dose_mg": 93.0, "avg_administrations": 22}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £27,736
first_seen: 2020-10-31
last_seen: 2024-07-12
first_seen_parent: 2017-08-10
last_seen_parent: 2024-06-22
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 187.3, "avg_administrations": 13}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 23 times with a 8.9 weekly interval (204.7 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £20,509
first_seen: 2018-12-19
last_seen: 2024-05-25
first_seen_parent: 2017-08-10
last_seen_parent: 2024-04-11
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 60.9, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 15 times with a 9.6 weekly interval (144.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £11,771
first_seen: 2020-07-29
last_seen: 2024-08-30
first_seen_parent: 2019-08-14
last_seen_parent: 2024-04-09
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 391.4, "avg_administrations": 19}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 21 times with a 4.8 weekly interval (100.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £18,083
first_seen: 2018-03-08
last_seen: 2025-12-20
first_seen_parent: 2018-05-28
last_seen_parent: 2024-08-26
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 87.2, "avg_administrations": 15}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 19 times with a 9.4 weekly interval (178.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - IBRUTINIB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £8,654
first_seen: 2021-08-25
last_seen: 2025-07-21
first_seen_parent: 2020-03-29
last_seen_parent: 2025-07-23
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 15 times with a 6.7 weekly interval (100.5 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 15 times with a 9.9 weekly interval (148.5 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 398.5, "avg_administrations": 11}, {"drug": "USTEKINUMAB", "avg_dose_mg": 168.4, "avg_administrations": 9}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - IBRUTINIB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £7,528
first_seen: 2021-01-05
last_seen: 2024-01-15
first_seen_parent: 2021-12-24
last_seen_parent: 2025-10-20
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 5 times with a 11.9 weekly interval (59.5 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 6 times with a 9.3 weekly interval (55.8 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 140.2, "avg_administrations": 26}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 365.9, "avg_administrations": 11}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £8,266
first_seen: 2019-05-05
last_seen: 2024-07-10
first_seen_parent: 2018-05-21
last_seen_parent: 2025-12-07
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 364.8, "avg_administrations": 30}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 22 times with a 3.3 weekly interval (72.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £21,809
first_seen: 2018-06-01
last_seen: 2025-10-09
first_seen_parent: 2017-08-23
last_seen_parent: 2024-07-15
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 76.1, "avg_administrations": 30}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 16 times with a 10.0 weekly interval (160.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £7,509
first_seen: 2020-03-07
last_seen: 2024-02-03
first_seen_parent: 2021-11-07
last_seen_parent: 2025-12-25
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 22 times with a 11.4 weekly interval (250.8 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 10 times with a 10.8 weekly interval (108.0 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 326.8, "avg_administrations": 13}, {"drug": "ETANERCEPT", "avg_dose_mg": 374.1, "avg_administrations": 14}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £4,907
first_seen: 2019-12-08
last_seen: 2024-06-05
first_seen_parent: 2021-04-10
last_seen_parent: 2025-06-18
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 29 times with a 8.6 weekly interval (249.4 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 29 times with a 8.3 weekly interval (240.7 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 60.7, "avg_administrations": 23}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 194.5, "avg_administrations": 7}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £4,017
first_seen: 2018-03-08
last_seen: 2024-08-22
first_seen_parent: 2019-08-16
last_seen_parent: 2025-05-30
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 413.1, "avg_administrations": 8}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 11 times with a 6.9 weekly interval (75.9 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £19,765
first_seen: 2018-10-24
last_seen: 2025-11-26
first_seen_parent: 2019-02-13
last_seen_parent: 2025-06-21
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 363.8, "avg_administrations": 17}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 18 times with a 5.5 weekly interval (99.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £21,849
first_seen: 2021-09-01
last_seen: 2024-09-26
first_seen_parent: 2017-02-17
last_seen_parent: 2025-07-16
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 347.2, "avg_administrations": 27}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 17 times with a 2.7 weekly interval (45.9 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £17,433
first_seen: 2019-08-29
last_seen: 2025-01-30
first_seen_parent: 2018-08-03
last_seen_parent: 2025-02-28
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 176.0, "avg_administrations": 10}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 11 times with a 9.5 weekly interval (104.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - TRASTUZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - TRASTUZUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £8,581
first_seen: 2022-01-02
last_seen: 2025-07-03
first_seen_parent: 2018-01-25
last_seen_parent: 2024-11-23
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 15 times with a 6.1 weekly interval (91.5 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 21 times with a 4.3 weekly interval (90.3 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 380.1, "avg_administrations": 30}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 434.4, "avg_administrations": 19}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £10,281
first_seen: 2021-01-26
last_seen: 2024-02-19
first_seen_parent: 2017-10-09
last_seen_parent: 2024-12-20
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 333.6, "avg_administrations": 17}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 27 times with a 7.1 weekly interval (191.7 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £9,396
first_seen: 2020-10-23
last_seen: 2025-03-04
first_seen_parent: 2019-04-03
last_seen_parent: 2024-08-24
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 105.6, "avg_administrations": 27}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 27 times with a 7.5 weekly interval (202.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £16,202
first_seen: 2020-05-12
last_seen: 2025-10-17
first_seen_parent: 2020-11-12
last_seen_parent: 2025-10-12
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 125.0, "avg_administrations": 6}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 23 times with a 11.3 weekly interval (259.9 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - RANIBIZUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £8,711
first_seen: 2020-01-27
last_seen: 2025-03-27
first_seen_parent: 2020-07-17
last_seen_parent: 2024-11-02
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 14 times with a 3.9 weekly interval (54.6 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 20 times with a 9.7 weekly interval (194.0 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 460.7, "avg_administrations": 21}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 272.1, "avg_administrations": 14}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £15,835
first_seen: 2021-09-10
last_seen: 2025-11-13
first_seen_parent: 2020-10-15
last_seen_parent: 2025-03-17
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 279.3, "avg_administrations": 29}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 13 times with a 9.5 weekly interval (123.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £12,456
first_seen: 2018-10-30
last_seen: 2024-11-08
first_seen_parent: 2020-09-26
last_seen_parent: 2024-04-01
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 92.0, "avg_administrations": 29}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 16 times with a 10.9 weekly interval (174.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £15,857
first_seen: 2021-03-09
last_seen: 2025-04-23
first_seen_parent: 2018-12-02
last_seen_parent: 2025-02-20
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 417.3, "avg_administrations": 22}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 29 times with a 6.5 weekly interval (188.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - INFLIXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - INFLIXIMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £16,055
first_seen: 2019-08-09
last_seen: 2024-01-29
first_seen_parent: 2019-06-19
last_seen_parent: 2024-12-27
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 13 times with a 5.2 weekly interval (67.6 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 25 times with a 3.8 weekly interval (95.0 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 218.8, "avg_administrations": 17}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 370.2, "avg_administrations": 23}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £10,724
first_seen: 2020-04-25
last_seen: 2024-03-29
first_seen_parent: 2019-05-18
last_seen_parent: 2025-09-06
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 235.8, "avg_administrations": 24}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 8 times with a 5.1 weekly interval (40.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ADALIMUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £12,361
first_seen: 2022-08-01
last_seen: 2024-05-18
first_seen_parent: 2020-03-18
last_seen_parent: 2024-10-27
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11 times with a 10.0 weekly interval (110.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 16 times with a 5.1 weekly interval (81.6 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 389.9, "avg_administrations": 6}, {"drug": "SECUKINUMAB", "avg_dose_mg": 207.9, "avg_administrations": 29}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £16,042
first_seen: 2021-09-07
last_seen: 2025-09-27
first_seen_parent: 2019-07-13
last_seen_parent: 2024-01-01
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 143.5, "avg_administrations": 28}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 30 times with a 3.9 weekly interval (117.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - RITUXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - RITUXIMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £13,415
first_seen: 2021-01-28
last_seen: 2024-02-28
first_seen_parent: 2021-01-23
last_seen_parent: 2024-08-21
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7 times with a 11.2 weekly interval (78.4 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 19 times with a 3.5 weekly interval (66.5 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 242.5, "avg_administrations": 23}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 300.5, "avg_administrations": 19}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - RITUXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - RITUXIMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £17,271
first_seen: 2020-08-18
last_seen: 2024-05-27
first_seen_parent: 2020-03-25
last_seen_parent: 2024-07-26
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 27 times with a 3.4 weekly interval (91.8 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 27 times with a 8.0 weekly interval (216.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 349.0, "avg_administrations": 25}, {"drug": "NIVOLUMAB", "avg_dose_mg": 92.9, "avg_administrations": 28}]


date_filter_id: all_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £15,875
first_seen: 2020-02-25
last_seen: 2025-09-14
first_seen_parent: 2020-09-01
last_seen_parent: 2024-06-06
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 419.9, "avg_administrations": 10}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11 times with a 9.1 weekly interval (100.1 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: PEMBROLIZUMAB
cost_pp_pa: £7,864
first_seen: 2021-04-29
last_seen: 2024-03-10
first_seen_parent: 2021-05-27
last_seen_parent: 2024-01-19
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - ETANERCEPT - PEMBROLIZUMAB

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 28 times with a 3.5 weekly interval (98.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 9 times with a 4.3 weekly interval (38.7 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 57.5, "avg_administrations": 12}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 132.7, "avg_administrations": 20}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £8,220
first_seen: 2018-01-17
last_seen: 2024-02-07
first_seen_parent: 2020-01-29
last_seen_parent: 2025-03-20
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 168.7, "avg_administrations": 24}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 25 times with a 6.0 weekly interval (150.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £16,928
first_seen: 2020-02-16
last_seen: 2025-09-02
first_seen_parent: 2019-08-04
last_seen_parent: 2025-05-08
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 292.4, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 18 times with a 7.4 weekly interval (133.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Atopic dermatitis - BARICITINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Atopic dermatitis - BARICITINIB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £14,540
first_seen: 2021-03-07
last_seen: 2024-07-15
first_seen_parent: 2019-10-09
last_seen_parent: 2024-11-23
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BARICITINIB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 23 times with a 7.4 weekly interval (170.2 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 11 times with a 5.4 weekly interval (59.4 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 168.5, "avg_administrations": 4}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 147.7, "avg_administrations": 11}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Atopic dermatitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £11,599
first_seen: 2019-07-24
last_seen: 2024-09-04
first_seen_parent: 2019-07-05
last_seen_parent: 2024-03-26
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 202.3, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 19 times with a 9.7 weekly interval (184.3 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - RITUXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - RITUXIMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £4,539
first_seen: 2019-01-04
last_seen: 2025-07-05
first_seen_parent: 2019-11-04
last_seen_parent: 2025-01-18
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 23 times with a 4.5 weekly interval (103.5 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 9 times with a 10.7 weekly interval (96.3 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 292.9, "avg_administrations": 27}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 195.0, "avg_administrations": 21}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £21,081
first_seen: 2020-09-16
last_seen: 2025-04-12
first_seen_parent: 2020-04-30
last_seen_parent: 2024-05-07
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 382.8, "avg_administrations": 28}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 13 times with a 2.3 weekly interval (29.9 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £8,631
first_seen: 2021-04-24
last_seen: 2025-06-12
first_seen_parent: 2018-04-24
last_seen_parent: 2025-09-30
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 496.0, "avg_administrations": 30}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 20 times with a 6.5 weekly interval (130.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer - BEVACIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £15,344
first_seen: 2020-05-21
last_seen: 2024-12-01
first_seen_parent: 2019-03-31
last_seen_parent: 2024-09-27
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 19 times with a 4.6 weekly interval (87.4 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 23 times with a 11.7 weekly interval (269.1 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 374.6, "avg_administrations": 5}, {"drug": "SECUKINUMAB", "avg_dose_mg": 210.5, "avg_administrations": 6}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer - BEVACIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £10,840
first_seen: 2019-03-01
last_seen: 2024-01-25
first_seen_parent: 2021-11-17
last_seen_parent: 2024-12-25
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 29 times with a 9.1 weekly interval (263.9 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 28 times with a 2.7 weekly interval (75.6 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 482.7, "avg_administrations": 13}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 252.1, "avg_administrations": 25}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £20,670
first_seen: 2021-08-19
last_seen: 2025-07-01
first_seen_parent: 2020-06-29
last_seen_parent: 2024-03-05
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 173.4, "avg_administrations": 4}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 23 times with a 6.1 weekly interval (140.3 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - USTEKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - USTEKINUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £15,699
first_seen: 2019-05-12
last_seen: 2024-09-24
first_seen_parent: 2020-04-13
last_seen_parent: 2025-03-20
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 26 times with a 11.0 weekly interval (286.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 6 times with a 6.2 weekly interval (37.2 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 267.5, "avg_administrations": 6}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 350.1, "avg_administrations": 23}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £6,288
first_seen: 2018-08-09
last_seen: 2024-07-28
first_seen_parent: 2017-05-23
last_seen_parent: 2025-10-20
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 82.2, "avg_administrations": 29}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 24 times with a 11.6 weekly interval (278.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £6,582
first_seen: 2018-03-18
last_seen: 2025-10-04
first_seen_parent: 2019-08-21
last_seen_parent: 2025-03-09
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 237.6, "avg_administrations": 18}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 14 times with a 5.4 weekly interval (75.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: BARICITINIB
cost_pp_pa: £6,276
first_seen: 2022-11-19
last_seen: 2025-04-11
first_seen_parent: 2020-07-02
last_seen_parent: 2025-01-24
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT - BARICITINIB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 25 times with a 5.3 weekly interval (132.5 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 8 times with a 7.7 weekly interval (61.6 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 457.4, "avg_administrations": 12}, {"drug": "BARICITINIB", "avg_dose_mg": 149.0, "avg_administrations": 19}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: TOCILIZUMAB
cost_pp_pa: £18,589
first_seen: 2022-04-30
last_seen: 2024-06-11
first_seen_parent: 2019-05-16
last_seen_parent: 2025-07-22
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT - TOCILIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 19 times with a 2.4 weekly interval (45.6 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 8 times with a 6.0 weekly interval (48.0 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 473.5, "avg_administrations": 14}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 75.8, "avg_administrations": 10}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £17,666
first_seen: 2021-10-28
last_seen: 2025-04-15
first_seen_parent: 2019-03-09
last_seen_parent: 2024-03-31
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 287.6, "avg_administrations": 22}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4 times with a 5.1 weekly interval (20.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £10,684
first_seen: 2018-07-10
last_seen: 2025-12-25
first_seen_parent: 2018-04-17
last_seen_parent: 2025-11-20
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 191.8, "avg_administrations": 7}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 16 times with a 8.0 weekly interval (128.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer - TRASTUZUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £14,790
first_seen: 2019-06-15
last_seen: 2024-05-11
first_seen_parent: 2018-07-16
last_seen_parent: 2025-01-15
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TRASTUZUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 22 times with a 6.5 weekly interval (143.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 12 times with a 2.6 weekly interval (31.2 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 354.1, "avg_administrations": 7}, {"drug": "NATALIZUMAB", "avg_dose_mg": 434.1, "avg_administrations": 6}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £6,703
first_seen: 2018-12-12
last_seen: 2025-05-21
first_seen_parent: 2017-08-18
last_seen_parent: 2025-11-11
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 369.2, "avg_administrations": 27}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 12 times with a 8.4 weekly interval (100.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £3,049
first_seen: 2021-01-17
last_seen: 2024-11-30
first_seen_parent: 2019-03-18
last_seen_parent: 2024-03-19
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 249.3, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 7 times with a 3.2 weekly interval (22.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £15,378
first_seen: 2020-12-05
last_seen: 2025-09-02
first_seen_parent: 2020-02-21
last_seen_parent: 2024-07-20
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 374.9, "avg_administrations": 22}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 20 times with a 8.9 weekly interval (178.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £16,782
first_seen: 2019-04-18
last_seen: 2025-09-19
first_seen_parent: 2019-06-10
last_seen_parent: 2025-07-16
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 53.3, "avg_administrations": 22}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 6 times with a 9.5 weekly interval (57.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £13,363
first_seen: 2019-10-16
last_seen: 2025-04-13
first_seen_parent: 2018-09-03
last_seen_parent: 2024-05-07
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 434.6, "avg_administrations": 30}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 10 times with a 5.6 weekly interval (56.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £16,869
first_seen: 2021-08-07
last_seen: 2024-10-07
first_seen_parent: 2017-01-03
last_seen_parent: 2024-09-14
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 437.9, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 18 times with a 3.9 weekly interval (70.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-Hodgkin lymphoma - RITUXIMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £13,825
first_seen: 2019-02-02
last_seen: 2024-09-27
first_seen_parent: 2019-06-15
last_seen_parent: 2025-02-18
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 10 times with a 10.1 weekly interval (101.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 10 times with a 8.5 weekly interval (85.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 148.8, "avg_administrations": 13}, {"drug": "NIVOLUMAB", "avg_dose_mg": 458.5, "avg_administrations": 24}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £18,506
first_seen: 2018-09-04
last_seen: 2025-04-24
first_seen_parent: 2019-01-17
last_seen_parent: 2025-05-21
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 493.3, "avg_administrations": 24}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 14 times with a 3.0 weekly interval (42.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: BARICITINIB
cost_pp_pa: £8,126
first_seen: 2019-02-21
last_seen: 2024-01-27
first_seen_parent: 2019-10-06
last_seen_parent: 2025-08-24
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB - BARICITINIB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 7 times with a 2.6 weekly interval (18.2 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 22 times with a 7.3 weekly interval (160.6 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 241.8, "avg_administrations": 23}, {"drug": "BARICITINIB", "avg_dose_mg": 471.4, "avg_administrations": 12}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: USTEKINUMAB
cost_pp_pa: £10,399
first_seen: 2022-10-06
last_seen: 2025-10-02
first_seen_parent: 2021-12-02
last_seen_parent: 2024-10-06
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB - USTEKINUMAB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 22 times with a 10.4 weekly interval (228.8 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 26 times with a 6.2 weekly interval (161.2 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 460.3, "avg_administrations": 4}, {"drug": "USTEKINUMAB", "avg_dose_mg": 317.3, "avg_administrations": 8}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £9,048
first_seen: 2021-06-18
last_seen: 2024-02-15
first_seen_parent: 2020-09-01
last_seen_parent: 2025-08-16
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 216.9, "avg_administrations": 11}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 27 times with a 5.5 weekly interval (148.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £14,057
first_seen: 2021-12-21
last_seen: 2025-04-03
first_seen_parent: 2020-09-02
last_seen_parent: 2025-11-18
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 427.2, "avg_administrations": 26}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 20 times with a 6.7 weekly interval (134.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £10,782
first_seen: 2019-01-20
last_seen: 2025-07-01
first_seen_parent: 2020-06-29
last_seen_parent: 2024-10-25
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - BEVACIZUMAB - OCRELIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 20 times with a 11.7 weekly interval (234.0 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 8 times with a 6.8 weekly interval (54.4 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 251.3, "avg_administrations": 18}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 176.4, "avg_administrations": 5}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £20,820
first_seen: 2020-10-30
last_seen: 2025-09-23
first_seen_parent: 2018-01-29
last_seen_parent: 2025-04-01
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 426.8, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 13 times with a 11.8 weekly interval (153.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - ADALIMUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £11,897
first_seen: 2022-12-01
last_seen: 2025-03-17
first_seen_parent: 2019-09-09
last_seen_parent: 2025-02-09
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 28 times with a 7.1 weekly interval (198.8 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 27 times with a 2.1 weekly interval (56.7 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 404.2, "avg_administrations": 9}, {"drug": "NATALIZUMAB", "avg_dose_mg": 256.9, "avg_administrations": 16}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £19,671
first_seen: 2020-03-23
last_seen: 2024-07-26
first_seen_parent: 2018-03-09
last_seen_parent: 2025-05-17
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 185.6, "avg_administrations": 6}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 2.1 weekly interval (37.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - SECUKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - SECUKINUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £16,778
first_seen: 2020-01-26
last_seen: 2025-09-17
first_seen_parent: 2019-07-12
last_seen_parent: 2025-08-13
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 13 times with a 9.4 weekly interval (122.2 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 24 times with a 6.0 weekly interval (144.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 450.6, "avg_administrations": 27}, {"drug": "RITUXIMAB", "avg_dose_mg": 298.0, "avg_administrations": 15}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - SECUKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - SECUKINUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £4,907
first_seen: 2022-10-09
last_seen: 2025-01-13
first_seen_parent: 2019-01-18
last_seen_parent: 2025-02-24
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 30 times with a 10.9 weekly interval (327.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 15 times with a 10.9 weekly interval (163.5 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 163.0, "avg_administrations": 16}, {"drug": "NIVOLUMAB", "avg_dose_mg": 347.4, "avg_administrations": 21}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £13,926
first_seen: 2019-03-20
last_seen: 2024-06-28
first_seen_parent: 2019-06-25
last_seen_parent: 2024-08-20
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 106.0, "avg_administrations": 30}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 17 times with a 2.5 weekly interval (42.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £28,331
first_seen: 2020-04-26
last_seen: 2025-09-30
first_seen_parent: 2017-10-24
last_seen_parent: 2025-10-01
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 413.9, "avg_administrations": 21}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 18 times with a 9.6 weekly interval (172.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - ETANERCEPT - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £7,942
first_seen: 2022-11-07
last_seen: 2025-08-09
first_seen_parent: 2019-08-26
last_seen_parent: 2024-10-15
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 10 times with a 11.6 weekly interval (116.0 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 6 times with a 8.1 weekly interval (48.6 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 478.6, "avg_administrations": 10}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 409.3, "avg_administrations": 18}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - ETANERCEPT - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £10,182
first_seen: 2019-03-02
last_seen: 2025-07-01
first_seen_parent: 2020-06-23
last_seen_parent: 2024-02-03
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 10 times with a 9.1 weekly interval (91.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 25 times with a 5.4 weekly interval (135.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 143.5, "avg_administrations": 20}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 385.3, "avg_administrations": 27}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £10,169
first_seen: 2021-04-08
last_seen: 2024-11-14
first_seen_parent: 2017-06-15
last_seen_parent: 2024-11-20
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 472.4, "avg_administrations": 18}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 29 times with a 8.5 weekly interval (246.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £13,033
first_seen: 2021-04-02
last_seen: 2024-03-14
first_seen_parent: 2019-08-27
last_seen_parent: 2024-10-01
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 7 times with a 11.0 weekly interval (77.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 28 times with a 9.0 weekly interval (252.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 269.8, "avg_administrations": 11}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 280.9, "avg_administrations": 18}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £6,838
first_seen: 2019-12-05
last_seen: 2025-04-07
first_seen_parent: 2019-07-03
last_seen_parent: 2024-01-31
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 16 times with a 4.8 weekly interval (76.8 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 14 times with a 4.3 weekly interval (60.2 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 283.5, "avg_administrations": 17}, {"drug": "BARICITINIB", "avg_dose_mg": 438.0, "avg_administrations": 15}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £7,180
first_seen: 2019-12-29
last_seen: 2024-05-14
first_seen_parent: 2019-01-26
last_seen_parent: 2025-06-23
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 230.4, "avg_administrations": 23}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 12 times with a 3.7 weekly interval (44.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Renal cell carcinoma - NIVOLUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £16,057
first_seen: 2022-07-31
last_seen: 2024-09-16
first_seen_parent: 2018-02-05
last_seen_parent: 2024-11-09
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NIVOLUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 29 times with a 9.8 weekly interval (284.2 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 6 times with a 5.0 weekly interval (30.0 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 361.3, "avg_administrations": 25}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 242.2, "avg_administrations": 20}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Renal cell carcinoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £8,808
first_seen: 2019-02-10
last_seen: 2025-10-20
first_seen_parent: 2020-04-01
last_seen_parent: 2025-09-11
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 370.1, "avg_administrations": 21}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 10 times with a 4.3 weekly interval (43.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ETANERCEPT
labels: PEMBROLIZUMAB
cost_pp_pa: £11,762
first_seen: 2022-08-10
last_seen: 2024-04-10
first_seen_parent: 2021-11-24
last_seen_parent: 2024-10-22
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ETANERCEPT - PEMBROLIZUMAB

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 8 times with a 8.3 weekly interval (66.4 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 26 times with a 7.4 weekly interval (192.4 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 64.2, "avg_administrations": 10}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 392.4, "avg_administrations": 24}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ETANERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ETANERCEPT - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £20,079
first_seen: 2019-02-01
last_seen: 2024-10-17
first_seen_parent: 2019-08-31
last_seen_parent: 2024-12-06
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 28 times with a 3.1 weekly interval (86.8 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 30 times with a 3.2 weekly interval (96.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 109.4, "avg_administrations": 8}, {"drug": "BARICITINIB", "avg_dose_mg": 376.8, "avg_administrations": 4}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £24,863
first_seen: 2020-10-20
last_seen: 2025-10-17
first_seen_parent: 2019-07-24
last_seen_parent: 2025-04-24
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 437.8, "avg_administrations": 24}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 14 times with a 6.1 weekly interval (85.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - BARICITINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - BARICITINIB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £15,511
first_seen: 2021-01-05
last_seen: 2024-01-07
first_seen_parent: 2020-10-31
last_seen_parent: 2024-10-16
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BARICITINIB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 22 times with a 11.3 weekly interval (248.6 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 8 times with a 11.4 weekly interval (91.2 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 56.9, "avg_administrations": 12}, {"drug": "TOFACITINIB", "avg_dose_mg": 437.6, "avg_administrations": 29}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £18,272
first_seen: 2020-01-15
last_seen: 2025-04-06
first_seen_parent: 2018-12-17
last_seen_parent: 2024-09-08
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 156.3, "avg_administrations": 30}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 14 times with a 10.7 weekly interval (149.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - RITUXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - RITUXIMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £19,327
first_seen: 2021-12-23
last_seen: 2025-05-25
first_seen_parent: 2018-05-20
last_seen_parent: 2024-05-21
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 21 times with a 6.0 weekly interval (126.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 16 times with a 8.5 weekly interval (136.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 381.5, "avg_administrations": 6}, {"drug": "ETANERCEPT", "avg_dose_mg": 181.5, "avg_administrations": 13}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £12,942
first_seen: 2019-01-16
last_seen: 2025-07-25
first_seen_parent: 2020-04-10
last_seen_parent: 2024-02-12
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 346.8, "avg_administrations": 24}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 12 times with a 6.1 weekly interval (73.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ADALIMUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £8,990
first_seen: 2021-11-09
last_seen: 2025-12-10
first_seen_parent: 2021-10-05
last_seen_parent: 2025-03-21
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7 times with a 11.3 weekly interval (79.1 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 26 times with a 5.5 weekly interval (143.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 443.6, "avg_administrations": 12}, {"drug": "NIVOLUMAB", "avg_dose_mg": 111.8, "avg_administrations": 19}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £8,242
first_seen: 2020-10-18
last_seen: 2025-04-25
first_seen_parent: 2020-06-22
last_seen_parent: 2024-04-23
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 349.6, "avg_administrations": 6}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 29 times with a 10.9 weekly interval (316.1 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - INFLIXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - INFLIXIMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £12,907
first_seen: 2021-08-02
last_seen: 2025-04-07
first_seen_parent: 2018-03-17
last_seen_parent: 2024-09-01
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 13 times with a 11.8 weekly interval (153.4 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 27 times with a 4.8 weekly interval (129.6 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 428.6, "avg_administrations": 12}, {"drug": "NIVOLUMAB", "avg_dose_mg": 429.1, "avg_administrations": 12}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - INFLIXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - INFLIXIMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £7,595
first_seen: 2021-09-04
last_seen: 2025-11-17
first_seen_parent: 2021-09-20
last_seen_parent: 2025-09-29
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 13 times with a 5.0 weekly interval (65.0 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 7 times with a 8.1 weekly interval (56.7 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 428.2, "avg_administrations": 28}, {"drug": "BARICITINIB", "avg_dose_mg": 235.3, "avg_administrations": 26}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £16,760
first_seen: 2018-08-17
last_seen: 2024-11-20
first_seen_parent: 2019-06-13
last_seen_parent: 2024-11-28
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 55.9, "avg_administrations": 5}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 14 times with a 10.7 weekly interval (149.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - INFLIXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - INFLIXIMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £14,354
first_seen: 2020-08-03
last_seen: 2025-06-25
first_seen_parent: 2019-04-21
last_seen_parent: 2024-02-10
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4 times with a 6.9 weekly interval (27.6 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 29 times with a 10.5 weekly interval (304.5 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 66.1, "avg_administrations": 8}, {"drug": "ADALIMUMAB", "avg_dose_mg": 332.2, "avg_administrations": 13}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £22,122
first_seen: 2019-09-19
last_seen: 2025-05-09
first_seen_parent: 2020-03-30
last_seen_parent: 2024-08-28
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 261.7, "avg_administrations": 26}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 29 times with a 11.6 weekly interval (336.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - VEDOLIZUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £3,967
first_seen: 2019-05-31
last_seen: 2025-02-13
first_seen_parent: 2019-12-07
last_seen_parent: 2024-08-11
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: VEDOLIZUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 30 times with a 11.6 weekly interval (348.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 11 times with a 12.0 weekly interval (132.0 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 493.2, "avg_administrations": 5}, {"drug": "ADALIMUMAB", "avg_dose_mg": 86.3, "avg_administrations": 12}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £11,130
first_seen: 2019-05-23
last_seen: 2025-04-29
first_seen_parent: 2018-02-23
last_seen_parent: 2025-07-13
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 329.2, "avg_administrations": 8}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 12 times with a 11.0 weekly interval (132.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £3,253
first_seen: 2021-07-14
last_seen: 2025-05-31
first_seen_parent: 2020-06-23
last_seen_parent: 2024-07-20
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 449.8, "avg_administrations": 27}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 24 times with a 5.2 weekly interval (124.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £5,639
first_seen: 2020-05-11
last_seen: 2025-08-05
first_seen_parent: 2018-06-20
last_seen_parent: 2025-07-24
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 106.5, "avg_administrations": 8}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 15 times with a 11.9 weekly interval (178.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £15,030
first_seen: 2020-03-11
last_seen: 2024-08-10
first_seen_parent: 2020-05-24
last_seen_parent: 2025-05-28
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 25 times with a 6.2 weekly interval (155.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 29 times with a 5.9 weekly interval (171.1 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 371.8, "avg_administrations": 30}, {"drug": "RITUXIMAB", "avg_dose_mg": 429.0, "avg_administrations": 15}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £13,533
first_seen: 2019-09-30
last_seen: 2024-05-15
first_seen_parent: 2020-07-13
last_seen_parent: 2024-05-12
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 386.7, "avg_administrations": 7}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 12 times with a 8.7 weekly interval (104.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £13,124
first_seen: 2020-07-04
last_seen: 2024-08-15
first_seen_parent: 2018-05-10
last_seen_parent: 2025-03-02
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 230.0, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 12 times with a 7.7 weekly interval (92.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £19,775
first_seen: 2020-06-22
last_seen: 2024-10-14
first_seen_parent: 2019-06-01
last_seen_parent: 2024-02-25
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 87.3, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 4 times with a 3.2 weekly interval (12.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £5,328
first_seen: 2021-01-23
last_seen: 2025-02-22
first_seen_parent: 2019-11-21
last_seen_parent: 2024-08-27
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB - PEMBROLIZUMAB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 4 times with a 8.3 weekly interval (33.2 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 26 times with a 11.0 weekly interval (286.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 324.2, "avg_administrations": 26}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 324.4, "avg_administrations": 21}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: TOFACITINIB
cost_pp_pa: £10,371
first_seen: 2020-05-03
last_seen: 2025-03-23
first_seen_parent: 2020-04-30
last_seen_parent: 2025-05-03
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB - TOFACITINIB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 17 times with a 4.8 weekly interval (81.6 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 22 times with a 2.1 weekly interval (46.2 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 418.4, "avg_administrations": 19}, {"drug": "TOFACITINIB", "avg_dose_mg": 50.1, "avg_administrations": 7}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £17,994
first_seen: 2018-07-10
last_seen: 2025-07-24
first_seen_parent: 2017-11-30
last_seen_parent: 2025-09-05
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 403.1, "avg_administrations": 30}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 18 times with a 11.3 weekly interval (203.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Atopic dermatitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £4,632
first_seen: 2021-03-24
last_seen: 2025-07-31
first_seen_parent: 2017-08-11
last_seen_parent: 2024-02-14
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 298.1, "avg_administrations": 24}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 30 times with a 11.3 weekly interval (339.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £11,267
first_seen: 2021-11-27
last_seen: 2025-03-05
first_seen_parent: 2021-10-08
last_seen_parent: 2024-02-20
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 24 times with a 6.9 weekly interval (165.6 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 10 times with a 5.1 weekly interval (51.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 96.4, "avg_administrations": 26}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 175.5, "avg_administrations": 11}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £18,059
first_seen: 2019-05-31
last_seen: 2025-05-12
first_seen_parent: 2017-04-10
last_seen_parent: 2024-11-22
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 258.6, "avg_administrations": 21}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5 times with a 4.6 weekly interval (23.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - IBRUTINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - IBRUTINIB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £2,569
first_seen: 2022-09-17
last_seen: 2024-12-04
first_seen_parent: 2018-10-15
last_seen_parent: 2025-09-04
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: IBRUTINIB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 21 times with a 4.8 weekly interval (100.8 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 8 times with a 9.7 weekly interval (77.6 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 119.7, "avg_administrations": 13}, {"drug": "RITUXIMAB", "avg_dose_mg": 487.2, "avg_administrations": 20}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - IBRUTINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - IBRUTINIB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £4,662
first_seen: 2020-07-09
last_seen: 2025-12-23
first_seen_parent: 2021-07-23
last_seen_parent: 2025-10-29
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: IBRUTINIB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 26 times with a 5.7 weekly interval (148.2 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 29 times with a 2.9 weekly interval (84.1 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 387.2, "avg_administrations": 17}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 305.4, "avg_administrations": 17}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £15,071
first_seen: 2018-07-20
last_seen: 2024-03-12
first_seen_parent: 2020-05-31
last_seen_parent: 2024-01-26
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 61.1, "avg_administrations": 20}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 12 times with a 10.4 weekly interval (124.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £13,169
first_seen: 2019-01-18
last_seen: 2024-08-28
first_seen_parent: 2017-09-16
last_seen_parent: 2024-06-08
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 151.6, "avg_administrations": 10}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5 times with a 8.2 weekly interval (41.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - INFLIXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - INFLIXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £14,737
first_seen: 2019-09-06
last_seen: 2025-03-19
first_seen_parent: 2021-03-01
last_seen_parent: 2024-05-08
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6 times with a 8.9 weekly interval (53.4 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 10 times with a 10.0 weekly interval (100.0 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 451.2, "avg_administrations": 18}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 405.4, "avg_administrations": 20}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - INFLIXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - INFLIXIMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £9,310
first_seen: 2020-10-06
last_seen: 2024-04-07
first_seen_parent: 2021-07-16
last_seen_parent: 2024-10-28
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 13 times with a 4.6 weekly interval (59.8 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 29 times with a 4.4 weekly interval (127.6 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 140.5, "avg_administrations": 13}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 313.4, "avg_administrations": 6}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £23,840
first_seen: 2018-07-03
last_seen: 2025-04-19
first_seen_parent: 2018-09-05
last_seen_parent: 2025-01-07
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 388.6, "avg_administrations": 25}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 11 times with a 6.4 weekly interval (70.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £8,479
first_seen: 2019-02-15
last_seen: 2025-07-04
first_seen_parent: 2019-09-26
last_seen_parent: 2024-08-18
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 479.9, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 25 times with a 10.9 weekly interval (272.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Diabetic macular oedema
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £9,097
first_seen: 2018-01-14
last_seen: 2024-05-28
first_seen_parent: 2020-09-24
last_seen_parent: 2025-07-23
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 412.4, "avg_administrations": 29}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 10 times with a 5.8 weekly interval (58.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £5,627
first_seen: 2019-10-13
last_seen: 2025-05-03
first_seen_parent: 2020-05-18
last_seen_parent: 2025-01-24
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 379.9, "avg_administrations": 26}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 13 times with a 11.5 weekly interval (149.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £11,622
first_seen: 2019-03-02
last_seen: 2024-08-24
first_seen_parent: 2017-01-19
last_seen_parent: 2024-11-14
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 75.3, "avg_administrations": 9}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 28 times with a 6.7 weekly interval (187.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Mantle cell lymphoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £17,235
first_seen: 2020-12-14
last_seen: 2024-01-15
first_seen_parent: 2018-08-08
last_seen_parent: 2025-06-16
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 498.2, "avg_administrations": 12}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 5 times with a 11.0 weekly interval (55.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £14,885
first_seen: 2020-09-21
last_seen: 2025-07-15
first_seen_parent: 2018-01-25
last_seen_parent: 2024-06-02
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 454.8, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 16 times with a 8.5 weekly interval (136.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £9,450
first_seen: 2020-02-19
last_seen: 2025-05-09
first_seen_parent: 2018-03-18
last_seen_parent: 2025-10-11
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 84.9, "avg_administrations": 13}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 15 times with a 5.7 weekly interval (85.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £8,861
first_seen: 2019-06-04
last_seen: 2024-08-01
first_seen_parent: 2018-02-17
last_seen_parent: 2024-05-23
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: OCRELIZUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 22 times with a 4.2 weekly interval (92.4 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 16 times with a 6.8 weekly interval (108.8 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 449.5, "avg_administrations": 18}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 130.2, "avg_administrations": 27}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £7,816
first_seen: 2020-07-27
last_seen: 2024-07-31
first_seen_parent: 2021-03-28
last_seen_parent: 2024-05-15
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: OCRELIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 26 times with a 5.5 weekly interval (143.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 27 times with a 8.7 weekly interval (234.9 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 303.6, "avg_administrations": 17}, {"drug": "INFLIXIMAB", "avg_dose_mg": 93.2, "avg_administrations": 21}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £6,658
first_seen: 2021-05-23
last_seen: 2025-01-16
first_seen_parent: 2018-01-27
last_seen_parent: 2024-09-30
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 127.9, "avg_administrations": 20}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 5 times with a 6.5 weekly interval (32.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - NATALIZUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £16,572
first_seen: 2020-03-28
last_seen: 2024-09-22
first_seen_parent: 2019-09-02
last_seen_parent: 2025-12-13
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NATALIZUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 30 times with a 8.7 weekly interval (261.0 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 14 times with a 2.2 weekly interval (30.8 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 62.3, "avg_administrations": 25}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 124.0, "avg_administrations": 30}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £16,762
first_seen: 2020-06-29
last_seen: 2024-11-03
first_seen_parent: 2018-07-29
last_seen_parent: 2024-04-13
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 307.7, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 10 times with a 7.2 weekly interval (72.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £23,820
first_seen: 2020-10-03
last_seen: 2024-06-05
first_seen_parent: 2019-11-29
last_seen_parent: 2024-12-25
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 21 times with a 2.1 weekly interval (44.1 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 24 times with a 3.4 weekly interval (81.6 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 92.8, "avg_administrations": 11}, {"drug": "NATALIZUMAB", "avg_dose_mg": 178.4, "avg_administrations": 11}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £21,033
first_seen: 2018-04-15
last_seen: 2025-05-08
first_seen_parent: 2020-09-24
last_seen_parent: 2025-07-18
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 377.1, "avg_administrations": 26}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 17 times with a 9.2 weekly interval (156.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £13,961
first_seen: 2019-04-26
last_seen: 2024-02-19
first_seen_parent: 2020-06-25
last_seen_parent: 2025-06-16
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 221.1, "avg_administrations": 23}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 5 times with a 7.9 weekly interval (39.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £14,262
first_seen: 2020-03-26
last_seen: 2024-03-07
first_seen_parent: 2018-07-06
last_seen_parent: 2025-10-17
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 101.0, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 26 times with a 2.6 weekly interval (67.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £13,129
first_seen: 2020-05-28
last_seen: 2024-07-28
first_seen_parent: 2018-01-15
last_seen_parent: 2025-06-24
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 241.1, "avg_administrations": 26}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 4 times with a 8.0 weekly interval (32.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £15,698
first_seen: 2021-06-18
last_seen: 2024-10-05
first_seen_parent: 2017-01-15
last_seen_parent: 2025-10-23
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 326.0, "avg_administrations": 21}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12 times with a 10.0 weekly interval (120.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - SECUKINUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - SECUKINUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,217
first_seen: 2019-09-08
last_seen: 2025-05-16
first_seen_parent: 2020-07-09
last_seen_parent: 2024-08-05
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 8 times with a 6.0 weekly interval (48.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 4 times with a 7.2 weekly interval (28.8 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 416.3, "avg_administrations": 23}, {"drug": "RITUXIMAB", "avg_dose_mg": 162.5, "avg_administrations": 30}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - SECUKINUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - SECUKINUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £5,663
first_seen: 2022-08-11
last_seen: 2024-11-27
first_seen_parent: 2021-09-02
last_seen_parent: 2025-05-03
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 15 times with a 11.9 weekly interval (178.5 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 29 times with a 6.2 weekly interval (179.8 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 91.9, "avg_administrations": 27}, {"drug": "IBRUTINIB", "avg_dose_mg": 121.9, "avg_administrations": 20}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £24,924
first_seen: 2020-02-26
last_seen: 2024-05-07
first_seen_parent: 2018-02-13
last_seen_parent: 2024-01-19
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 441.1, "avg_administrations": 10}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 20 times with a 9.6 weekly interval (192.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £18,204
first_seen: 2019-08-04
last_seen: 2024-03-09
first_seen_parent: 2019-01-22
last_seen_parent: 2024-07-19
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 165.6, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 30 times with a 10.5 weekly interval (315.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - ETANERCEPT - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £8,496
first_seen: 2022-01-24
last_seen: 2024-08-02
first_seen_parent: 2018-09-23
last_seen_parent: 2025-03-14
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 4 times with a 9.3 weekly interval (37.2 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 21 times with a 8.3 weekly interval (174.3 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 374.9, "avg_administrations": 14}, {"drug": "ADALIMUMAB", "avg_dose_mg": 252.9, "avg_administrations": 26}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £7,011
first_seen: 2019-12-28
last_seen: 2024-02-22
first_seen_parent: 2018-08-17
last_seen_parent: 2025-03-01
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 365.9, "avg_administrations": 26}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 24 times with a 9.1 weekly interval (218.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £15,947
first_seen: 2021-02-28
last_seen: 2025-07-29
first_seen_parent: 2019-06-30
last_seen_parent: 2025-12-23
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 402.9, "avg_administrations": 11}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 27 times with a 6.9 weekly interval (186.3 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Renal cell carcinoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £9,274
first_seen: 2021-08-06
last_seen: 2024-12-07
first_seen_parent: 2018-07-14
last_seen_parent: 2024-11-11
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 111.7, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 18 times with a 3.4 weekly interval (61.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - INFLIXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - INFLIXIMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £6,172
first_seen: 2021-07-17
last_seen: 2024-08-03
first_seen_parent: 2021-08-22
last_seen_parent: 2024-02-24
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 21 times with a 3.2 weekly interval (67.2 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 6 times with a 11.9 weekly interval (71.4 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 141.9, "avg_administrations": 18}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 293.2, "avg_administrations": 6}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £18,857
first_seen: 2018-08-10
last_seen: 2024-08-29
first_seen_parent: 2020-10-14
last_seen_parent: 2024-05-27
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 275.8, "avg_administrations": 13}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 14 times with a 11.2 weekly interval (156.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £7,275
first_seen: 2021-01-03
last_seen: 2024-02-17
first_seen_parent: 2019-12-18
last_seen_parent: 2024-09-17
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 4 times with a 4.6 weekly interval (18.4 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 29 times with a 10.7 weekly interval (310.3 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 436.6, "avg_administrations": 23}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 486.1, "avg_administrations": 11}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £6,993
first_seen: 2019-01-09
last_seen: 2025-09-16
first_seen_parent: 2018-03-25
last_seen_parent: 2024-02-09
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 16 times with a 2.3 weekly interval (36.8 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 28 times with a 9.3 weekly interval (260.4 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 245.1, "avg_administrations": 4}, {"drug": "ADALIMUMAB", "avg_dose_mg": 152.2, "avg_administrations": 13}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £6,184
first_seen: 2018-01-19
last_seen: 2025-11-29
first_seen_parent: 2018-02-20
last_seen_parent: 2025-09-03
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 111.9, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 23 times with a 9.6 weekly interval (220.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £12,549
first_seen: 2021-01-03
last_seen: 2025-11-30
first_seen_parent: 2021-02-26
last_seen_parent: 2024-02-01
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOFACITINIB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 8 times with a 4.7 weekly interval (37.6 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 29 times with a 7.8 weekly interval (226.2 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 255.9, "avg_administrations": 6}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 159.8, "avg_administrations": 11}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £5,555
first_seen: 2020-10-26
last_seen: 2024-02-03
first_seen_parent: 2020-12-01
last_seen_parent: 2024-03-14
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOFACITINIB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 27 times with a 8.2 weekly interval (221.4 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 14 times with a 10.8 weekly interval (151.2 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 376.6, "avg_administrations": 4}, {"drug": "BARICITINIB", "avg_dose_mg": 186.0, "avg_administrations": 6}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £17,774
first_seen: 2018-07-26
last_seen: 2024-07-29
first_seen_parent: 2019-07-16
last_seen_parent: 2024-02-10
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 295.6, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 20 times with a 9.4 weekly interval (188.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £23,048
first_seen: 2020-06-27
last_seen: 2025-02-22
first_seen_parent: 2019-06-23
last_seen_parent: 2024-12-14
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 141.2, "avg_administrations": 22}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 28 times with a 4.8 weekly interval (134.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £27,476
first_seen: 2018-07-17
last_seen: 2024-04-03
first_seen_parent: 2020-05-15
last_seen_parent: 2024-01-02
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 273.2, "avg_administrations": 13}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 12 times with a 5.6 weekly interval (67.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £13,263
first_seen: 2019-04-23
last_seen: 2024-10-16
first_seen_parent: 2019-09-22
last_seen_parent: 2024-11-26
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 51.4, "avg_administrations": 11}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 14 times with a 10.2 weekly interval (142.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £24,122
first_seen: 2018-05-25
last_seen: 2025-06-01
first_seen_parent: 2020-01-03
last_seen_parent: 2025-07-05
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 172.9, "avg_administrations": 5}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 18 times with a 5.8 weekly interval (104.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £18,812
first_seen: 2020-03-05
last_seen: 2025-03-24
first_seen_parent: 2018-11-26
last_seen_parent: 2025-07-12
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 295.2, "avg_administrations": 25}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 18 times with a 10.1 weekly interval (181.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Uveitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £6,198
first_seen: 2021-10-29
last_seen: 2025-06-03
first_seen_parent: 2019-04-11
last_seen_parent: 2024-12-07
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 368.4, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 15 times with a 8.8 weekly interval (132.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - AFLIBERCEPT - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £8,069
first_seen: 2019-12-22
last_seen: 2024-03-25
first_seen_parent: 2019-01-25
last_seen_parent: 2024-08-09
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 20 times with a 4.0 weekly interval (80.0 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 17 times with a 9.7 weekly interval (164.9 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 215.9, "avg_administrations": 27}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 246.4, "avg_administrations": 16}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £9,889
first_seen: 2021-05-22
last_seen: 2024-11-29
first_seen_parent: 2017-10-08
last_seen_parent: 2024-08-05
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 362.9, "avg_administrations": 5}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 8 times with a 7.7 weekly interval (61.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £10,143
first_seen: 2019-11-06
last_seen: 2024-04-07
first_seen_parent: 2018-07-20
last_seen_parent: 2024-08-04
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 229.8, "avg_administrations": 21}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 9 times with a 8.5 weekly interval (76.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £10,004
first_seen: 2018-05-04
last_seen: 2024-02-17
first_seen_parent: 2019-11-11
last_seen_parent: 2025-11-01
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 270.4, "avg_administrations": 17}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 14 times with a 10.0 weekly interval (140.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - SECUKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - SECUKINUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £6,691
first_seen: 2021-10-10
last_seen: 2025-10-13
first_seen_parent: 2018-09-11
last_seen_parent: 2024-04-12
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 26 times with a 9.2 weekly interval (239.2 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 12 times with a 6.2 weekly interval (74.4 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 467.3, "avg_administrations": 21}, {"drug": "BARICITINIB", "avg_dose_mg": 323.2, "avg_administrations": 20}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - SECUKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - SECUKINUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £7,192
first_seen: 2020-10-03
last_seen: 2024-10-20
first_seen_parent: 2021-04-24
last_seen_parent: 2024-10-06
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 30 times with a 6.9 weekly interval (207.0 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 22 times with a 2.3 weekly interval (50.6 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 456.2, "avg_administrations": 25}, {"drug": "IBRUTINIB", "avg_dose_mg": 80.0, "avg_administrations": 10}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £14,545
first_seen: 2020-11-19
last_seen: 2025-10-08
first_seen_parent: 2018-01-01
last_seen_parent: 2025-02-16
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 433.9, "avg_administrations": 29}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 21 times with a 9.7 weekly interval (203.7 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Atopic dermatitis - BARICITINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Atopic dermatitis - BARICITINIB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £4,879
first_seen: 2019-05-20
last_seen: 2025-06-11
first_seen_parent: 2019-05-08
last_seen_parent: 2024-02-24
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BARICITINIB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 14 times with a 6.0 weekly interval (84.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 29 times with a 5.2 weekly interval (150.8 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 77.7, "avg_administrations": 10}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 429.4, "avg_administrations": 4}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Atopic dermatitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £10,758
first_seen: 2019-11-27
last_seen: 2024-06-18
first_seen_parent: 2017-10-03
last_seen_parent: 2024-03-11
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 325.6, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 24 times with a 6.4 weekly interval (153.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - RITUXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - RITUXIMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £18,560
first_seen: 2022-07-21
last_seen: 2025-11-22
first_seen_parent: 2018-10-08
last_seen_parent: 2025-07-27
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 15 times with a 4.4 weekly interval (66.0 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 10 times with a 4.6 weekly interval (46.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 168.5, "avg_administrations": 6}, {"drug": "IBRUTINIB", "avg_dose_mg": 80.9, "avg_administrations": 25}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £27,447
first_seen: 2019-03-07
last_seen: 2025-10-09
first_seen_parent: 2020-04-14
last_seen_parent: 2024-06-14
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 352.6, "avg_administrations": 4}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 18 times with a 7.8 weekly interval (140.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £22,071
first_seen: 2018-07-24
last_seen: 2025-06-24
first_seen_parent: 2020-06-14
last_seen_parent: 2025-05-04
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 355.2, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 7 times with a 7.6 weekly interval (53.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Colorectal cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £6,904
first_seen: 2019-01-12
last_seen: 2025-04-16
first_seen_parent: 2017-06-11
last_seen_parent: 2024-10-14
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 267.6, "avg_administrations": 11}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 7 times with a 6.3 weekly interval (44.1 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £7,646
first_seen: 2021-05-20
last_seen: 2024-05-06
first_seen_parent: 2020-11-16
last_seen_parent: 2025-11-11
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 376.0, "avg_administrations": 19}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 10 times with a 2.2 weekly interval (22.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - USTEKINUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £17,531
first_seen: 2022-08-21
last_seen: 2024-02-16
first_seen_parent: 2019-04-18
last_seen_parent: 2024-05-14
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 24 times with a 6.3 weekly interval (151.2 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 29 times with a 4.7 weekly interval (136.3 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 242.9, "avg_administrations": 24}, {"drug": "IBRUTINIB", "avg_dose_mg": 467.9, "avg_administrations": 30}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £8,768
first_seen: 2020-01-09
last_seen: 2024-09-10
first_seen_parent: 2020-08-18
last_seen_parent: 2025-10-24
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 336.4, "avg_administrations": 7}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 7 times with a 5.6 weekly interval (39.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema - AFLIBERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema - AFLIBERCEPT - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £3,644
first_seen: 2022-11-04
last_seen: 2024-12-02
first_seen_parent: 2020-07-28
last_seen_parent: 2025-12-05
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 22 times with a 4.7 weekly interval (103.4 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 17 times with a 2.2 weekly interval (37.4 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 369.7, "avg_administrations": 7}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 300.1, "avg_administrations": 22}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema - AFLIBERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema - AFLIBERCEPT - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £11,121
first_seen: 2020-02-27
last_seen: 2024-07-14
first_seen_parent: 2018-09-25
last_seen_parent: 2024-01-03
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 9 times with a 2.4 weekly interval (21.6 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 23 times with a 5.1 weekly interval (117.3 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 298.4, "avg_administrations": 20}, {"drug": "ETANERCEPT", "avg_dose_mg": 330.6, "avg_administrations": 14}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £5,579
first_seen: 2020-04-10
last_seen: 2025-02-05
first_seen_parent: 2017-06-26
last_seen_parent: 2025-08-13
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 240.6, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 23 times with a 2.4 weekly interval (55.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Giant cell arteritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £8,573
first_seen: 2020-12-15
last_seen: 2025-11-03
first_seen_parent: 2017-02-27
last_seen_parent: 2025-06-28
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 272.5, "avg_administrations": 10}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 17 times with a 7.4 weekly interval (125.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £17,041
first_seen: 2018-07-27
last_seen: 2024-11-26
first_seen_parent: 2019-07-01
last_seen_parent: 2025-10-13
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 334.0, "avg_administrations": 15}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 4 times with a 5.5 weekly interval (22.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Mantle cell lymphoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £13,350
first_seen: 2020-10-03
last_seen: 2025-07-17
first_seen_parent: 2020-12-18
last_seen_parent: 2025-01-29
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 102.3, "avg_administrations": 27}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 14 times with a 3.5 weekly interval (49.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Melanoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £9,585
first_seen: 2021-01-22
last_seen: 2024-05-10
first_seen_parent: 2017-12-08
last_seen_parent: 2025-06-28
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 343.1, "avg_administrations": 27}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 17 times with a 5.7 weekly interval (96.9 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma - LENALIDOMIDE
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma - LENALIDOMIDE - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £9,461
first_seen: 2021-11-06
last_seen: 2025-01-09
first_seen_parent: 2021-02-05
last_seen_parent: 2025-07-12
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: LENALIDOMIDE|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 16 times with a 10.0 weekly interval (160.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 13 times with a 3.4 weekly interval (44.2 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 58.3, "avg_administrations": 6}, {"drug": "NIVOLUMAB", "avg_dose_mg": 140.7, "avg_administrations": 8}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £6,696
first_seen: 2019-03-31
last_seen: 2024-10-15
first_seen_parent: 2017-07-05
last_seen_parent: 2024-05-01
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 476.8, "avg_administrations": 17}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 25 times with a 8.3 weekly interval (207.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £8,248
first_seen: 2022-11-17
last_seen: 2024-12-20
first_seen_parent: 2018-01-23
last_seen_parent: 2025-05-26
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: OCRELIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 14 times with a 3.7 weekly interval (51.8 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 17 times with a 7.3 weekly interval (124.1 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 295.4, "avg_administrations": 26}, {"drug": "INFLIXIMAB", "avg_dose_mg": 65.2, "avg_administrations": 18}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £10,024
first_seen: 2022-08-07
last_seen: 2024-05-23
first_seen_parent: 2021-02-05
last_seen_parent: 2025-02-27
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: OCRELIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 18 times with a 9.2 weekly interval (165.6 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 21 times with a 4.7 weekly interval (98.7 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 460.3, "avg_administrations": 14}, {"drug": "TOFACITINIB", "avg_dose_mg": 122.6, "avg_administrations": 9}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £5,649
first_seen: 2019-06-08
last_seen: 2025-10-27
first_seen_parent: 2019-03-31
last_seen_parent: 2024-12-03
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 303.4, "avg_administrations": 14}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 9 times with a 11.5 weekly interval (103.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £13,789
first_seen: 2018-12-20
last_seen: 2025-01-26
first_seen_parent: 2019-12-27
last_seen_parent: 2025-06-08
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 357.4, "avg_administrations": 15}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 26 times with a 7.8 weekly interval (202.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £20,489
first_seen: 2019-02-01
last_seen: 2024-01-10
first_seen_parent: 2019-05-10
last_seen_parent: 2025-07-05
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 283.4, "avg_administrations": 20}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4 times with a 5.1 weekly interval (20.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £18,374
first_seen: 2021-08-14
last_seen: 2025-06-02
first_seen_parent: 2019-09-11
last_seen_parent: 2024-06-01
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 161.8, "avg_administrations": 27}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 4 times with a 4.7 weekly interval (18.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £11,239
first_seen: 2021-05-25
last_seen: 2025-05-16
first_seen_parent: 2018-02-22
last_seen_parent: 2025-05-15
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 53.7, "avg_administrations": 5}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 25 times with a 8.3 weekly interval (207.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £6,948
first_seen: 2020-08-19
last_seen: 2025-06-30
first_seen_parent: 2019-09-26
last_seen_parent: 2025-04-21
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 24 times with a 8.3 weekly interval (199.2 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 12 times with a 5.2 weekly interval (62.4 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 126.5, "avg_administrations": 4}, {"drug": "RITUXIMAB", "avg_dose_mg": 121.3, "avg_administrations": 19}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: SECUKINUMAB
cost_pp_pa: £8,293
first_seen: 2021-06-14
last_seen: 2024-04-09
first_seen_parent: 2019-06-25
last_seen_parent: 2025-12-23
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB - SECUKINUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 24 times with a 6.6 weekly interval (158.4 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 24 times with a 10.5 weekly interval (252.0 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 389.0, "avg_administrations": 13}, {"drug": "SECUKINUMAB", "avg_dose_mg": 480.9, "avg_administrations": 29}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £7,763
first_seen: 2021-03-18
last_seen: 2025-11-17
first_seen_parent: 2017-11-25
last_seen_parent: 2024-01-06
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 381.3, "avg_administrations": 25}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 9 times with a 6.4 weekly interval (57.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £20,243
first_seen: 2018-09-18
last_seen: 2025-05-08
first_seen_parent: 2017-01-12
last_seen_parent: 2025-08-26
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 498.5, "avg_administrations": 30}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9 times with a 10.8 weekly interval (97.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - SECUKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - SECUKINUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £22,427
first_seen: 2022-10-22
last_seen: 2025-11-20
first_seen_parent: 2019-06-12
last_seen_parent: 2024-02-20
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 7 times with a 4.8 weekly interval (33.6 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 23 times with a 5.5 weekly interval (126.5 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 409.9, "avg_administrations": 6}, {"drug": "IBRUTINIB", "avg_dose_mg": 258.3, "avg_administrations": 28}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - SECUKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - SECUKINUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £17,315
first_seen: 2020-03-20
last_seen: 2025-03-25
first_seen_parent: 2018-06-28
last_seen_parent: 2025-11-13
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 14 times with a 11.9 weekly interval (166.6 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 19 times with a 10.9 weekly interval (207.1 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 481.6, "avg_administrations": 12}, {"drug": "USTEKINUMAB", "avg_dose_mg": 217.2, "avg_administrations": 29}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £16,488
first_seen: 2019-12-23
last_seen: 2025-12-15
first_seen_parent: 2019-12-26
last_seen_parent: 2024-06-27
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 151.8, "avg_administrations": 27}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 7 times with a 8.7 weekly interval (60.9 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £7,340
first_seen: 2018-12-06
last_seen: 2024-01-07
first_seen_parent: 2018-08-26
last_seen_parent: 2024-05-04
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 144.7, "avg_administrations": 16}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 11 times with a 8.3 weekly interval (91.3 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £8,153
first_seen: 2019-11-14
last_seen: 2025-03-07
first_seen_parent: 2018-12-06
last_seen_parent: 2024-07-02
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 57.7, "avg_administrations": 25}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 29 times with a 11.4 weekly interval (330.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £15,231
first_seen: 2019-08-20
last_seen: 2024-03-18
first_seen_parent: 2019-09-21
last_seen_parent: 2025-04-19
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 434.4, "avg_administrations": 8}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 12 times with a 11.1 weekly interval (133.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £22,257
first_seen: 2018-12-15
last_seen: 2025-01-20
first_seen_parent: 2020-03-09
last_seen_parent: 2025-08-28
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 365.6, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 18 times with a 5.7 weekly interval (102.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £17,763
first_seen: 2021-10-17
last_seen: 2024-10-11
first_seen_parent: 2019-09-21
last_seen_parent: 2024-05-25
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 253.0, "avg_administrations": 20}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10 times with a 7.2 weekly interval (72.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOFACITINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOFACITINIB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £8,957
first_seen: 2019-09-07
last_seen: 2024-08-04
first_seen_parent: 2018-10-09
last_seen_parent: 2024-10-15
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOFACITINIB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 9 times with a 10.8 weekly interval (97.2 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 25 times with a 10.6 weekly interval (265.0 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 432.0, "avg_administrations": 23}, {"drug": "BARICITINIB", "avg_dose_mg": 471.0, "avg_administrations": 6}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £19,142
first_seen: 2018-08-03
last_seen: 2024-12-12
first_seen_parent: 2019-08-28
last_seen_parent: 2025-04-24
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 131.1, "avg_administrations": 30}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 14 times with a 11.2 weekly interval (156.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOCILIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOCILIZUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £10,084
first_seen: 2022-06-10
last_seen: 2025-11-16
first_seen_parent: 2021-08-10
last_seen_parent: 2025-02-17
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOCILIZUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 22 times with a 11.9 weekly interval (261.8 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 18 times with a 11.3 weekly interval (203.4 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 360.2, "avg_administrations": 13}, {"drug": "NATALIZUMAB", "avg_dose_mg": 277.7, "avg_administrations": 19}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOCILIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOCILIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £4,588
first_seen: 2019-01-20
last_seen: 2025-01-05
first_seen_parent: 2018-12-28
last_seen_parent: 2025-01-05
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOCILIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 22 times with a 6.3 weekly interval (138.6 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 13 times with a 2.5 weekly interval (32.5 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 456.3, "avg_administrations": 20}, {"drug": "INFLIXIMAB", "avg_dose_mg": 307.1, "avg_administrations": 5}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £11,678
first_seen: 2021-05-03
last_seen: 2024-05-31
first_seen_parent: 2020-07-04
last_seen_parent: 2025-08-12
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 401.0, "avg_administrations": 13}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 28 times with a 7.4 weekly interval (207.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £13,825
first_seen: 2021-01-15
last_seen: 2024-01-19
first_seen_parent: 2018-07-15
last_seen_parent: 2025-09-20
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 202.5, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 19 times with a 6.6 weekly interval (125.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - INFLIXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - INFLIXIMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £9,971
first_seen: 2022-02-09
last_seen: 2025-10-24
first_seen_parent: 2020-01-21
last_seen_parent: 2024-06-26
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 15 times with a 10.3 weekly interval (154.5 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 19 times with a 9.4 weekly interval (178.6 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 406.8, "avg_administrations": 15}, {"drug": "BARICITINIB", "avg_dose_mg": 91.1, "avg_administrations": 12}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £9,836
first_seen: 2021-03-10
last_seen: 2025-11-19
first_seen_parent: 2020-01-25
last_seen_parent: 2024-12-21
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 195.9, "avg_administrations": 24}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 14 times with a 10.5 weekly interval (147.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £12,397
first_seen: 2021-06-23
last_seen: 2025-07-12
first_seen_parent: 2018-11-11
last_seen_parent: 2025-02-13
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 180.0, "avg_administrations": 25}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 10 times with a 11.5 weekly interval (115.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £3,625
first_seen: 2018-03-08
last_seen: 2025-01-08
first_seen_parent: 2017-11-21
last_seen_parent: 2025-08-17
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 266.1, "avg_administrations": 15}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 20 times with a 9.0 weekly interval (180.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £4,291
first_seen: 2020-02-12
last_seen: 2025-09-02
first_seen_parent: 2020-11-01
last_seen_parent: 2025-12-24
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 73.3, "avg_administrations": 19}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 10 times with a 8.2 weekly interval (82.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £27,570
first_seen: 2020-11-18
last_seen: 2024-08-31
first_seen_parent: 2017-02-16
last_seen_parent: 2024-06-16
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 300.1, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8 times with a 3.8 weekly interval (30.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - AFLIBERCEPT - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £5,261
first_seen: 2020-05-30
last_seen: 2025-02-28
first_seen_parent: 2019-10-01
last_seen_parent: 2024-11-14
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 7 times with a 7.9 weekly interval (55.3 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 19 times with a 4.7 weekly interval (89.3 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 130.3, "avg_administrations": 19}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 444.0, "avg_administrations": 7}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - AFLIBERCEPT - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £10,789
first_seen: 2020-04-07
last_seen: 2024-07-31
first_seen_parent: 2018-06-17
last_seen_parent: 2024-11-10
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 20 times with a 2.7 weekly interval (54.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 25 times with a 3.7 weekly interval (92.5 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 216.0, "avg_administrations": 17}, {"drug": "ADALIMUMAB", "avg_dose_mg": 54.3, "avg_administrations": 7}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £24,318
first_seen: 2018-11-08
last_seen: 2025-05-31
first_seen_parent: 2017-06-16
last_seen_parent: 2025-07-05
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 418.4, "avg_administrations": 14}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 9 times with a 9.1 weekly interval (81.9 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - RANIBIZUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £2,745
first_seen: 2022-03-06
last_seen: 2024-01-13
first_seen_parent: 2021-01-12
last_seen_parent: 2025-06-16
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RANIBIZUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 6 times with a 11.1 weekly interval (66.6 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 16 times with a 3.4 weekly interval (54.4 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 387.2, "avg_administrations": 27}, {"drug": "BARICITINIB", "avg_dose_mg": 214.2, "avg_administrations": 11}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £15,360
first_seen: 2021-10-12
last_seen: 2024-04-30
first_seen_parent: 2019-03-15
last_seen_parent: 2025-07-22
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 97.5, "avg_administrations": 15}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 24 times with a 8.4 weekly interval (201.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £10,759
first_seen: 2020-08-14
last_seen: 2025-02-21
first_seen_parent: 2020-02-06
last_seen_parent: 2025-09-14
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 174.3, "avg_administrations": 19}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 27 times with a 7.5 weekly interval (202.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: RANIBIZUMAB
cost_pp_pa: £9,097
first_seen: 2019-04-28
last_seen: 2024-04-15
first_seen_parent: 2021-11-07
last_seen_parent: 2025-05-01
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB - RANIBIZUMAB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 12 times with a 3.6 weekly interval (43.2 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 8 times with a 11.1 weekly interval (88.8 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 351.9, "avg_administrations": 12}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 257.9, "avg_administrations": 26}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: OCRELIZUMAB
cost_pp_pa: £5,219
first_seen: 2021-11-12
last_seen: 2024-02-17
first_seen_parent: 2018-12-14
last_seen_parent: 2025-08-04
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB - OCRELIZUMAB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 12 times with a 2.7 weekly interval (32.4 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 30 times with a 10.5 weekly interval (315.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 422.4, "avg_administrations": 23}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 294.9, "avg_administrations": 15}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £7,773
first_seen: 2018-01-01
last_seen: 2024-07-16
first_seen_parent: 2019-07-13
last_seen_parent: 2025-08-07
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 137.1, "avg_administrations": 7}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 26 times with a 10.7 weekly interval (278.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Atopic dermatitis - BARICITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Atopic dermatitis - BARICITINIB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £19,176
first_seen: 2022-05-19
last_seen: 2025-05-24
first_seen_parent: 2021-05-12
last_seen_parent: 2024-04-16
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 9 times with a 6.0 weekly interval (54.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 19 times with a 2.5 weekly interval (47.5 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 405.8, "avg_administrations": 28}, {"drug": "ADALIMUMAB", "avg_dose_mg": 388.2, "avg_administrations": 11}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Atopic dermatitis - BARICITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Atopic dermatitis - BARICITINIB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £6,913
first_seen: 2022-12-03
last_seen: 2025-12-10
first_seen_parent: 2018-12-28
last_seen_parent: 2025-02-16
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 4 times with a 8.6 weekly interval (34.4 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 15 times with a 11.0 weekly interval (165.0 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 468.5, "avg_administrations": 9}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 146.7, "avg_administrations": 29}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Atopic dermatitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £17,029
first_seen: 2018-06-01
last_seen: 2024-11-18
first_seen_parent: 2019-02-05
last_seen_parent: 2025-09-25
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 75.4, "avg_administrations": 17}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 7 times with a 10.3 weekly interval (72.1 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - RITUXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - RITUXIMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £16,860
first_seen: 2019-06-04
last_seen: 2025-01-03
first_seen_parent: 2018-04-20
last_seen_parent: 2024-11-04
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 30 times with a 6.2 weekly interval (186.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 19 times with a 8.5 weekly interval (161.5 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 333.4, "avg_administrations": 6}, {"drug": "USTEKINUMAB", "avg_dose_mg": 488.8, "avg_administrations": 14}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - RITUXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - RITUXIMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £12,370
first_seen: 2019-01-29
last_seen: 2024-03-30
first_seen_parent: 2018-12-01
last_seen_parent: 2024-06-29
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4 times with a 7.4 weekly interval (29.6 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 10 times with a 4.9 weekly interval (49.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 318.0, "avg_administrations": 24}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 178.2, "avg_administrations": 16}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £5,861
first_seen: 2021-10-28
last_seen: 2024-01-02
first_seen_parent: 2020-06-02
last_seen_parent: 2025-06-16
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 442.5, "avg_administrations": 9}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 14 times with a 10.4 weekly interval (145.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £3,772
first_seen: 2020-05-16
last_seen: 2025-01-14
first_seen_parent: 2019-12-20
last_seen_parent: 2024-04-03
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 132.7, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 29 times with a 10.2 weekly interval (295.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer - BEVACIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £7,415
first_seen: 2020-12-16
last_seen: 2025-06-28
first_seen_parent: 2019-05-05
last_seen_parent: 2025-02-02
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 23 times with a 5.3 weekly interval (121.9 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 12 times with a 11.5 weekly interval (138.0 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 388.1, "avg_administrations": 27}, {"drug": "RITUXIMAB", "avg_dose_mg": 313.6, "avg_administrations": 19}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer - BEVACIZUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £7,028
first_seen: 2019-06-03
last_seen: 2024-02-27
first_seen_parent: 2021-11-15
last_seen_parent: 2025-03-14
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 22 times with a 9.2 weekly interval (202.4 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 10 times with a 8.0 weekly interval (80.0 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 166.2, "avg_administrations": 8}, {"drug": "USTEKINUMAB", "avg_dose_mg": 239.7, "avg_administrations": 18}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £4,349
first_seen: 2020-08-06
last_seen: 2024-08-24
first_seen_parent: 2017-07-27
last_seen_parent: 2024-08-27
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 264.1, "avg_administrations": 28}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 17 times with a 11.0 weekly interval (187.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - USTEKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - USTEKINUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £13,242
first_seen: 2020-05-20
last_seen: 2025-09-24
first_seen_parent: 2020-05-08
last_seen_parent: 2024-11-22
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: USTEKINUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 4 times with a 5.7 weekly interval (22.8 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 21 times with a 11.4 weekly interval (239.4 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 273.1, "avg_administrations": 23}, {"drug": "TOFACITINIB", "avg_dose_mg": 414.1, "avg_administrations": 30}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £5,199
first_seen: 2018-04-09
last_seen: 2024-11-15
first_seen_parent: 2020-02-20
last_seen_parent: 2024-09-05
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 289.3, "avg_administrations": 5}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 17 times with a 4.0 weekly interval (68.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £15,500
first_seen: 2021-12-23
last_seen: 2024-12-01
first_seen_parent: 2020-12-12
last_seen_parent: 2025-07-08
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 333.5, "avg_administrations": 10}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 10 times with a 8.1 weekly interval (81.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £4,473
first_seen: 2018-01-31
last_seen: 2025-01-20
first_seen_parent: 2018-06-20
last_seen_parent: 2024-03-26
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 428.6, "avg_administrations": 19}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 25 times with a 10.1 weekly interval (252.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £4,758
first_seen: 2020-01-19
last_seen: 2025-12-09
first_seen_parent: 2019-05-12
last_seen_parent: 2024-12-21
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 378.2, "avg_administrations": 8}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 24 times with a 10.9 weekly interval (261.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £21,108
first_seen: 2018-08-07
last_seen: 2024-06-23
first_seen_parent: 2019-04-29
last_seen_parent: 2025-04-16
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 66.6, "avg_administrations": 30}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 26 times with a 3.2 weekly interval (83.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £15,823
first_seen: 2019-08-17
last_seen: 2024-04-21
first_seen_parent: 2018-08-09
last_seen_parent: 2024-05-29
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TRASTUZUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 7 times with a 7.6 weekly interval (53.2 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 25 times with a 4.7 weekly interval (117.5 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 399.9, "avg_administrations": 7}, {"drug": "NATALIZUMAB", "avg_dose_mg": 143.6, "avg_administrations": 24}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £8,249
first_seen: 2021-12-26
last_seen: 2024-12-04
first_seen_parent: 2020-01-11
last_seen_parent: 2024-10-03
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 369.7, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 17 times with a 11.0 weekly interval (187.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Mantle cell lymphoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £8,432
first_seen: 2020-06-06
last_seen: 2024-09-23
first_seen_parent: 2017-05-30
last_seen_parent: 2025-05-31
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 292.9, "avg_administrations": 28}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 7 times with a 9.2 weekly interval (64.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Melanoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £20,481
first_seen: 2021-09-21
last_seen: 2025-08-28
first_seen_parent: 2018-11-28
last_seen_parent: 2024-05-22
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 478.6, "avg_administrations": 28}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 10 times with a 5.6 weekly interval (56.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple myeloma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £14,392
first_seen: 2018-01-12
last_seen: 2024-08-31
first_seen_parent: 2020-03-07
last_seen_parent: 2024-01-15
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 221.2, "avg_administrations": 8}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 8 times with a 8.2 weekly interval (65.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £8,180
first_seen: 2018-05-07
last_seen: 2024-03-13
first_seen_parent: 2019-07-06
last_seen_parent: 2024-12-23
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 339.7, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 9 times with a 11.1 weekly interval (99.9 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £5,669
first_seen: 2018-08-29
last_seen: 2025-12-23
first_seen_parent: 2019-09-19
last_seen_parent: 2025-04-17
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 174.8, "avg_administrations": 23}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 9 times with a 6.1 weekly interval (54.9 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-Hodgkin lymphoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £14,804
first_seen: 2018-09-25
last_seen: 2024-03-25
first_seen_parent: 2019-08-18
last_seen_parent: 2024-12-01
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 416.4, "avg_administrations": 5}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 24 times with a 5.3 weekly interval (127.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: USTEKINUMAB
cost_pp_pa: £19,106
first_seen: 2020-12-02
last_seen: 2024-05-26
first_seen_parent: 2018-09-02
last_seen_parent: 2024-12-08
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB - USTEKINUMAB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 28 times with a 3.3 weekly interval (92.4 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 28 times with a 9.9 weekly interval (277.2 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 229.6, "avg_administrations": 30}, {"drug": "USTEKINUMAB", "avg_dose_mg": 384.8, "avg_administrations": 4}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £13,987
first_seen: 2020-07-23
last_seen: 2024-06-22
first_seen_parent: 2018-06-08
last_seen_parent: 2025-08-07
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 106.6, "avg_administrations": 17}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 25 times with a 6.9 weekly interval (172.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: BEVACIZUMAB
cost_pp_pa: £13,078
first_seen: 2022-10-01
last_seen: 2024-06-30
first_seen_parent: 2021-08-23
last_seen_parent: 2025-12-18
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB - BEVACIZUMAB

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 25 times with a 11.2 weekly interval (280.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 7 times with a 2.1 weekly interval (14.7 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 394.1, "avg_administrations": 16}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 331.9, "avg_administrations": 26}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: TOFACITINIB
cost_pp_pa: £13,707
first_seen: 2019-09-05
last_seen: 2025-03-13
first_seen_parent: 2021-06-19
last_seen_parent: 2025-04-12
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB - TOFACITINIB

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 9 times with a 5.4 weekly interval (48.6 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 19 times with a 3.3 weekly interval (62.7 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 381.3, "avg_administrations": 18}, {"drug": "TOFACITINIB", "avg_dose_mg": 237.9, "avg_administrations": 8}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £11,142
first_seen: 2021-04-14
last_seen: 2025-07-06
first_seen_parent: 2017-12-18
last_seen_parent: 2024-04-04
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 449.7, "avg_administrations": 26}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 30 times with a 2.3 weekly interval (69.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £15,075
first_seen: 2021-10-30
last_seen: 2025-02-17
first_seen_parent: 2020-08-22
last_seen_parent: 2024-08-09
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB - VEDOLIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 4 times with a 11.4 weekly interval (45.6 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 10 times with a 10.9 weekly interval (109.0 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 409.5, "avg_administrations": 18}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 68.1, "avg_administrations": 12}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: SECUKINUMAB
cost_pp_pa: £20,663
first_seen: 2021-05-11
last_seen: 2025-05-15
first_seen_parent: 2019-08-29
last_seen_parent: 2025-11-24
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB - SECUKINUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 4 times with a 5.2 weekly interval (20.8 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 30 times with a 2.9 weekly interval (87.0 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 61.1, "avg_administrations": 19}, {"drug": "SECUKINUMAB", "avg_dose_mg": 332.4, "avg_administrations": 11}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £5,914
first_seen: 2021-08-24
last_seen: 2024-02-17
first_seen_parent: 2020-08-16
last_seen_parent: 2024-12-28
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 378.5, "avg_administrations": 9}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 27 times with a 9.0 weekly interval (243.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £10,738
first_seen: 2019-06-04
last_seen: 2025-11-02
first_seen_parent: 2017-01-25
last_seen_parent: 2024-03-31
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 471.6, "avg_administrations": 26}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21 times with a 5.2 weekly interval (109.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £3,200
first_seen: 2020-01-14
last_seen: 2025-07-06
first_seen_parent: 2020-11-04
last_seen_parent: 2024-03-06
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 25 times with a 3.3 weekly interval (82.5 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 11 times with a 4.2 weekly interval (46.2 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 225.4, "avg_administrations": 26}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 53.7, "avg_administrations": 26}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £5,600
first_seen: 2018-09-02
last_seen: 2025-10-12
first_seen_parent: 2018-09-28
last_seen_parent: 2024-03-19
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 407.4, "avg_administrations": 24}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 15 times with a 8.3 weekly interval (124.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £10,328
first_seen: 2021-08-04
last_seen: 2025-12-07
first_seen_parent: 2017-11-26
last_seen_parent: 2024-08-02
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 333.3, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 22 times with a 11.4 weekly interval (250.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £24,729
first_seen: 2020-04-07
last_seen: 2024-09-29
first_seen_parent: 2020-09-17
last_seen_parent: 2025-09-22
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 80.4, "avg_administrations": 14}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 4 times with a 4.6 weekly interval (18.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £21,440
first_seen: 2020-07-11
last_seen: 2025-12-01
first_seen_parent: 2019-09-04
last_seen_parent: 2025-05-23
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 169.6, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 22 times with a 7.1 weekly interval (156.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £9,387
first_seen: 2021-04-06
last_seen: 2024-10-09
first_seen_parent: 2020-06-04
last_seen_parent: 2024-08-22
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 11 times with a 5.3 weekly interval (58.3 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 10 times with a 7.5 weekly interval (75.0 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 69.7, "avg_administrations": 23}, {"drug": "NATALIZUMAB", "avg_dose_mg": 322.6, "avg_administrations": 24}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £14,053
first_seen: 2021-06-25
last_seen: 2024-06-28
first_seen_parent: 2019-02-23
last_seen_parent: 2024-11-08
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 13 times with a 2.1 weekly interval (27.3 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 15 times with a 4.1 weekly interval (61.5 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 184.7, "avg_administrations": 5}, {"drug": "ETANERCEPT", "avg_dose_mg": 316.0, "avg_administrations": 27}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £17,715
first_seen: 2021-08-14
last_seen: 2024-07-25
first_seen_parent: 2018-11-13
last_seen_parent: 2024-03-16
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 142.1, "avg_administrations": 15}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 12 times with a 11.7 weekly interval (140.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB
labels: LENALIDOMIDE
cost_pp_pa: £18,938
first_seen: 2021-05-28
last_seen: 2024-01-14
first_seen_parent: 2018-04-20
last_seen_parent: 2024-01-07
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB - LENALIDOMIDE

average_spacing:
<br><b>TOFACITINIB</b><br>On average given 7 times with a 9.8 weekly interval (68.6 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 13 times with a 3.5 weekly interval (45.5 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 58.4, "avg_administrations": 19}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 411.9, "avg_administrations": 10}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £5,971
first_seen: 2019-02-15
last_seen: 2024-10-21
first_seen_parent: 2018-01-30
last_seen_parent: 2025-08-18
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 20 times with a 10.5 weekly interval (210.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 9 times with a 9.0 weekly interval (81.0 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 62.7, "avg_administrations": 29}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 475.4, "avg_administrations": 11}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £17,584
first_seen: 2020-08-12
last_seen: 2024-01-07
first_seen_parent: 2020-07-30
last_seen_parent: 2024-12-24
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 366.4, "avg_administrations": 22}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 8 times with a 6.1 weekly interval (48.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £15,512
first_seen: 2022-11-29
last_seen: 2025-10-14
first_seen_parent: 2019-04-18
last_seen_parent: 2025-11-16
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 8 times with a 2.2 weekly interval (17.6 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 13 times with a 10.6 weekly interval (137.8 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 350.7, "avg_administrations": 30}, {"drug": "RITUXIMAB", "avg_dose_mg": 471.1, "avg_administrations": 25}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £18,962
first_seen: 2020-12-27
last_seen: 2025-04-28
first_seen_parent: 2020-09-21
last_seen_parent: 2024-07-30
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 131.0, "avg_administrations": 13}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 7 times with a 3.2 weekly interval (22.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £10,632
first_seen: 2020-05-21
last_seen: 2024-10-24
first_seen_parent: 2020-06-22
last_seen_parent: 2025-08-15
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 480.4, "avg_administrations": 25}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 29 times with a 4.6 weekly interval (133.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £21,839
first_seen: 2021-03-27
last_seen: 2024-10-23
first_seen_parent: 2020-06-26
last_seen_parent: 2024-04-22
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 24 times with a 6.2 weekly interval (148.8 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 14 times with a 7.4 weekly interval (103.6 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 161.0, "avg_administrations": 27}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 78.6, "avg_administrations": 15}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £8,832
first_seen: 2021-06-15
last_seen: 2025-06-25
first_seen_parent: 2020-12-15
last_seen_parent: 2025-04-23
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 9 times with a 11.7 weekly interval (105.3 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 22 times with a 6.9 weekly interval (151.8 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 206.1, "avg_administrations": 25}, {"drug": "ETANERCEPT", "avg_dose_mg": 238.2, "avg_administrations": 5}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £8,134
first_seen: 2019-02-20
last_seen: 2025-05-03
first_seen_parent: 2018-03-02
last_seen_parent: 2024-10-17
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 354.2, "avg_administrations": 15}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 30 times with a 11.3 weekly interval (339.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £19,063
first_seen: 2021-11-05
last_seen: 2025-04-08
first_seen_parent: 2019-07-03
last_seen_parent: 2024-10-05
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 370.3, "avg_administrations": 9}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 23 times with a 9.9 weekly interval (227.7 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £21,013
first_seen: 2020-12-30
last_seen: 2025-10-29
first_seen_parent: 2020-02-09
last_seen_parent: 2024-09-27
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: VEDOLIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 13 times with a 8.8 weekly interval (114.4 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 23 times with a 3.7 weekly interval (85.1 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 371.0, "avg_administrations": 28}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 386.0, "avg_administrations": 18}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £12,704
first_seen: 2019-11-05
last_seen: 2025-07-28
first_seen_parent: 2019-11-18
last_seen_parent: 2024-12-12
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 385.1, "avg_administrations": 26}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 18 times with a 11.6 weekly interval (208.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £7,493
first_seen: 2018-04-13
last_seen: 2025-03-18
first_seen_parent: 2017-08-13
last_seen_parent: 2024-01-19
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 403.3, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 26 times with a 11.3 weekly interval (293.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Uveitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £21,694
first_seen: 2020-07-05
last_seen: 2025-03-02
first_seen_parent: 2019-08-02
last_seen_parent: 2025-05-07
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 458.4, "avg_administrations": 26}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 28 times with a 10.8 weekly interval (302.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £9,822
first_seen: 2021-06-09
last_seen: 2024-09-01
first_seen_parent: 2019-12-02
last_seen_parent: 2025-08-18
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 436.8, "avg_administrations": 15}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 28 times with a 8.8 weekly interval (246.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £21,683
first_seen: 2018-07-27
last_seen: 2024-07-31
first_seen_parent: 2018-10-29
last_seen_parent: 2024-11-26
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 321.8, "avg_administrations": 26}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 9 times with a 2.0 weekly interval (18.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £19,430
first_seen: 2020-07-01
last_seen: 2024-05-29
first_seen_parent: 2018-04-03
last_seen_parent: 2025-03-06
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 14 times with a 7.2 weekly interval (100.8 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 23 times with a 8.0 weekly interval (184.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 172.0, "avg_administrations": 27}, {"drug": "NATALIZUMAB", "avg_dose_mg": 334.4, "avg_administrations": 11}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £15,932
first_seen: 2020-07-01
last_seen: 2025-07-09
first_seen_parent: 2019-05-26
last_seen_parent: 2025-09-02
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 143.9, "avg_administrations": 7}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 17 times with a 10.5 weekly interval (178.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - SECUKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - SECUKINUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £13,685
first_seen: 2022-12-03
last_seen: 2024-03-27
first_seen_parent: 2018-04-06
last_seen_parent: 2024-01-24
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 13 times with a 11.4 weekly interval (148.2 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 19 times with a 5.2 weekly interval (98.8 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 203.1, "avg_administrations": 19}, {"drug": "ETANERCEPT", "avg_dose_mg": 313.1, "avg_administrations": 28}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - SECUKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - SECUKINUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £9,143
first_seen: 2019-12-01
last_seen: 2025-01-09
first_seen_parent: 2018-10-20
last_seen_parent: 2025-02-10
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 25 times with a 6.2 weekly interval (155.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 21 times with a 11.1 weekly interval (233.1 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 438.7, "avg_administrations": 24}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 493.3, "avg_administrations": 5}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £12,849
first_seen: 2020-04-16
last_seen: 2025-10-21
first_seen_parent: 2018-06-15
last_seen_parent: 2024-03-12
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 133.3, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 18 times with a 11.4 weekly interval (205.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Atopic dermatitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £20,878
first_seen: 2020-11-26
last_seen: 2025-08-17
first_seen_parent: 2020-03-07
last_seen_parent: 2024-02-28
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 165.1, "avg_administrations": 24}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 13 times with a 9.3 weekly interval (120.9 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - RITUXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - RITUXIMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £12,349
first_seen: 2022-05-10
last_seen: 2024-12-20
first_seen_parent: 2018-09-23
last_seen_parent: 2025-05-14
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 24 times with a 3.6 weekly interval (86.4 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 26 times with a 10.1 weekly interval (262.6 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 350.8, "avg_administrations": 22}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 369.8, "avg_administrations": 13}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £4,900
first_seen: 2020-10-08
last_seen: 2025-06-19
first_seen_parent: 2018-11-16
last_seen_parent: 2025-09-28
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 114.0, "avg_administrations": 12}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11 times with a 6.3 weekly interval (69.3 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £16,446
first_seen: 2021-05-13
last_seen: 2024-07-01
first_seen_parent: 2018-06-05
last_seen_parent: 2024-11-13
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 104.1, "avg_administrations": 20}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 15 times with a 7.6 weekly interval (114.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer - BEVACIZUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £13,499
first_seen: 2019-11-08
last_seen: 2024-11-12
first_seen_parent: 2018-03-17
last_seen_parent: 2024-07-25
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 25 times with a 8.5 weekly interval (212.5 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 18 times with a 10.4 weekly interval (187.2 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 101.1, "avg_administrations": 6}, {"drug": "USTEKINUMAB", "avg_dose_mg": 176.7, "avg_administrations": 5}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer - BEVACIZUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £19,067
first_seen: 2021-07-13
last_seen: 2024-12-14
first_seen_parent: 2020-09-14
last_seen_parent: 2024-11-11
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 23 times with a 6.9 weekly interval (158.7 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 9 times with a 6.4 weekly interval (57.6 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 132.8, "avg_administrations": 29}, {"drug": "IBRUTINIB", "avg_dose_mg": 97.3, "avg_administrations": 19}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £6,405
first_seen: 2020-08-19
last_seen: 2024-12-07
first_seen_parent: 2017-01-12
last_seen_parent: 2025-09-26
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 78.1, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 23 times with a 5.4 weekly interval (124.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - USTEKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - USTEKINUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £10,482
first_seen: 2020-11-30
last_seen: 2025-10-10
first_seen_parent: 2018-02-25
last_seen_parent: 2025-06-23
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: USTEKINUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 19 times with a 11.1 weekly interval (210.9 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 25 times with a 8.6 weekly interval (215.0 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 473.1, "avg_administrations": 11}, {"drug": "RITUXIMAB", "avg_dose_mg": 284.2, "avg_administrations": 27}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £19,673
first_seen: 2018-06-11
last_seen: 2025-03-14
first_seen_parent: 2018-07-31
last_seen_parent: 2024-02-07
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 441.2, "avg_administrations": 28}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 20 times with a 9.7 weekly interval (194.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - INFLIXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - INFLIXIMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £7,624
first_seen: 2019-12-14
last_seen: 2024-12-03
first_seen_parent: 2021-03-21
last_seen_parent: 2024-10-02
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 25 times with a 2.4 weekly interval (60.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 27 times with a 4.0 weekly interval (108.0 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 336.0, "avg_administrations": 20}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 273.4, "avg_administrations": 14}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - INFLIXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - INFLIXIMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £16,332
first_seen: 2019-11-13
last_seen: 2024-08-25
first_seen_parent: 2018-09-02
last_seen_parent: 2024-04-10
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 25 times with a 2.8 weekly interval (70.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 10 times with a 6.9 weekly interval (69.0 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 484.9, "avg_administrations": 30}, {"drug": "ETANERCEPT", "avg_dose_mg": 423.5, "avg_administrations": 21}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £13,129
first_seen: 2021-07-14
last_seen: 2024-04-22
first_seen_parent: 2018-03-24
last_seen_parent: 2024-12-14
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 162.3, "avg_administrations": 19}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 29 times with a 3.0 weekly interval (87.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £4,590
first_seen: 2020-07-15
last_seen: 2025-06-10
first_seen_parent: 2018-03-16
last_seen_parent: 2025-01-31
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 292.4, "avg_administrations": 13}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 19 times with a 9.5 weekly interval (180.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £8,086
first_seen: 2018-01-22
last_seen: 2024-10-13
first_seen_parent: 2018-12-15
last_seen_parent: 2024-02-07
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 189.7, "avg_administrations": 20}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 21 times with a 4.1 weekly interval (86.1 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Giant cell arteritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £3,175
first_seen: 2021-12-08
last_seen: 2024-09-04
first_seen_parent: 2020-03-20
last_seen_parent: 2024-11-07
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 378.1, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 17 times with a 5.2 weekly interval (88.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £6,101
first_seen: 2019-12-26
last_seen: 2025-11-20
first_seen_parent: 2019-08-26
last_seen_parent: 2024-02-02
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 191.6, "avg_administrations": 16}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 25 times with a 6.7 weekly interval (167.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma - IBRUTINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma - IBRUTINIB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £5,017
first_seen: 2020-03-05
last_seen: 2024-04-25
first_seen_parent: 2018-09-03
last_seen_parent: 2024-10-29
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 21 times with a 7.8 weekly interval (163.8 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 24 times with a 7.6 weekly interval (182.4 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 117.2, "avg_administrations": 30}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 266.8, "avg_administrations": 6}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma - IBRUTINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma - IBRUTINIB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £9,225
first_seen: 2022-06-29
last_seen: 2024-11-12
first_seen_parent: 2021-03-29
last_seen_parent: 2025-07-28
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 10 times with a 9.4 weekly interval (94.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 8 times with a 4.0 weekly interval (32.0 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 455.6, "avg_administrations": 23}, {"drug": "USTEKINUMAB", "avg_dose_mg": 134.1, "avg_administrations": 30}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £11,453
first_seen: 2018-06-08
last_seen: 2025-07-24
first_seen_parent: 2017-04-13
last_seen_parent: 2024-01-10
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 143.1, "avg_administrations": 5}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 30 times with a 3.9 weekly interval (117.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £8,749
first_seen: 2021-09-30
last_seen: 2024-10-31
first_seen_parent: 2017-09-12
last_seen_parent: 2024-06-03
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 145.4, "avg_administrations": 27}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 18 times with a 4.9 weekly interval (88.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple myeloma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £21,062
first_seen: 2019-04-13
last_seen: 2025-02-12
first_seen_parent: 2017-03-29
last_seen_parent: 2025-11-10
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 276.7, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 17 times with a 11.3 weekly interval (192.1 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - OCRELIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £14,592
first_seen: 2020-01-08
last_seen: 2024-08-24
first_seen_parent: 2019-09-21
last_seen_parent: 2024-07-03
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: OCRELIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 11 times with a 8.3 weekly interval (91.3 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 22 times with a 6.4 weekly interval (140.8 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 391.4, "avg_administrations": 24}, {"drug": "SECUKINUMAB", "avg_dose_mg": 431.7, "avg_administrations": 20}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £16,991
first_seen: 2019-03-27
last_seen: 2025-03-25
first_seen_parent: 2017-09-26
last_seen_parent: 2024-09-15
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 418.7, "avg_administrations": 9}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 28 times with a 3.7 weekly interval (103.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £11,645
first_seen: 2021-10-17
last_seen: 2025-03-14
first_seen_parent: 2019-08-22
last_seen_parent: 2024-11-30
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 334.7, "avg_administrations": 6}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 9 times with a 8.2 weekly interval (73.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma - RITUXIMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £17,317
first_seen: 2022-06-06
last_seen: 2025-01-23
first_seen_parent: 2019-07-10
last_seen_parent: 2025-03-21
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 12 times with a 6.7 weekly interval (80.4 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 20 times with a 10.3 weekly interval (206.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 131.5, "avg_administrations": 14}, {"drug": "SECUKINUMAB", "avg_dose_mg": 411.6, "avg_administrations": 14}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £18,244
first_seen: 2019-02-04
last_seen: 2024-12-05
first_seen_parent: 2020-06-24
last_seen_parent: 2025-05-31
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 210.2, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 6 times with a 8.2 weekly interval (49.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £5,201
first_seen: 2020-11-30
last_seen: 2025-11-10
first_seen_parent: 2019-09-08
last_seen_parent: 2024-09-04
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 376.3, "avg_administrations": 20}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 26 times with a 3.5 weekly interval (91.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: TOFACITINIB
cost_pp_pa: £4,261
first_seen: 2020-06-04
last_seen: 2025-10-15
first_seen_parent: 2019-09-08
last_seen_parent: 2024-07-28
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB - TOFACITINIB

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 19 times with a 8.4 weekly interval (159.6 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 4 times with a 7.1 weekly interval (28.4 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 402.1, "avg_administrations": 16}, {"drug": "TOFACITINIB", "avg_dose_mg": 346.4, "avg_administrations": 19}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: OCRELIZUMAB
cost_pp_pa: £13,178
first_seen: 2020-01-02
last_seen: 2025-12-14
first_seen_parent: 2018-07-19
last_seen_parent: 2025-11-24
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB - OCRELIZUMAB

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 15 times with a 8.3 weekly interval (124.5 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 22 times with a 10.4 weekly interval (228.8 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 412.8, "avg_administrations": 13}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 65.6, "avg_administrations": 22}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £11,995
first_seen: 2020-06-09
last_seen: 2025-04-15
first_seen_parent: 2019-02-20
last_seen_parent: 2024-12-24
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 53.9, "avg_administrations": 5}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 20 times with a 12.0 weekly interval (240.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £12,722
first_seen: 2018-03-04
last_seen: 2024-02-17
first_seen_parent: 2017-04-29
last_seen_parent: 2025-03-17
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 251.4, "avg_administrations": 19}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 20 times with a 10.0 weekly interval (200.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £6,817
first_seen: 2021-11-16
last_seen: 2025-10-17
first_seen_parent: 2018-01-28
last_seen_parent: 2024-03-17
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 182.4, "avg_administrations": 27}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8 times with a 2.3 weekly interval (18.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - SECUKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - SECUKINUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £11,463
first_seen: 2022-09-03
last_seen: 2024-01-01
first_seen_parent: 2020-10-12
last_seen_parent: 2025-11-26
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 18 times with a 10.9 weekly interval (196.2 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 10 times with a 10.1 weekly interval (101.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 239.1, "avg_administrations": 7}, {"drug": "USTEKINUMAB", "avg_dose_mg": 425.3, "avg_administrations": 12}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £10,482
first_seen: 2018-10-20
last_seen: 2025-09-10
first_seen_parent: 2017-04-18
last_seen_parent: 2025-08-30
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 234.5, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 22 times with a 2.4 weekly interval (52.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £19,602
first_seen: 2020-01-03
last_seen: 2024-11-14
first_seen_parent: 2020-03-28
last_seen_parent: 2024-08-04
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 389.7, "avg_administrations": 20}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 13 times with a 8.4 weekly interval (109.2 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £17,305
first_seen: 2021-07-30
last_seen: 2024-06-16
first_seen_parent: 2020-04-05
last_seen_parent: 2024-07-28
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 115.8, "avg_administrations": 8}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 12 times with a 5.8 weekly interval (69.6 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £6,570
first_seen: 2020-05-05
last_seen: 2024-03-15
first_seen_parent: 2020-12-28
last_seen_parent: 2025-02-27
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 214.6, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 29 times with a 5.0 weekly interval (145.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma - NIVOLUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £14,118
first_seen: 2020-05-29
last_seen: 2025-12-05
first_seen_parent: 2020-11-07
last_seen_parent: 2025-04-19
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 15 times with a 2.6 weekly interval (39.0 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 9 times with a 3.1 weekly interval (27.9 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 371.3, "avg_administrations": 5}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 357.6, "avg_administrations": 8}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £13,415
first_seen: 2019-12-15
last_seen: 2025-07-11
first_seen_parent: 2018-03-12
last_seen_parent: 2025-09-19
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 314.8, "avg_administrations": 9}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 10 times with a 2.9 weekly interval (29.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £11,453
first_seen: 2018-03-14
last_seen: 2025-07-11
first_seen_parent: 2017-11-01
last_seen_parent: 2025-08-25
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 111.8, "avg_administrations": 20}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 18 times with a 11.6 weekly interval (208.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £19,449
first_seen: 2020-03-08
last_seen: 2025-02-10
first_seen_parent: 2018-02-08
last_seen_parent: 2024-09-11
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 238.2, "avg_administrations": 21}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4 times with a 9.1 weekly interval (36.4 weeks total treatment length)


